<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Nutrients</journal-id>
<journal-id journal-id-type="iso-abbrev">Nutrients</journal-id>
<journal-id journal-id-type="publisher-id">nutrients</journal-id>
<journal-title-group>
<journal-title>Nutrients</journal-title>
</journal-title-group>
<issn pub-type="epub">2072-6643</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32521760</article-id>
<article-id pub-id-type="pmc">7352781</article-id>
<article-id pub-id-type="doi">10.3390/nu12061718</article-id>
<article-id pub-id-type="publisher-id">nutrients-12-01718</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Diet Supplementation, Probiotics, and Nutraceuticals in SARS-CoV-2 Infection: A Scoping Review</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2606-657X</contrib-id>
<name>
<surname>Infusino</surname>
<given-names>Fabio</given-names>
</name>
<xref ref-type="aff" rid="af1-nutrients-12-01718">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Marazzato</surname>
<given-names>Massimiliano</given-names>
</name>
<xref ref-type="aff" rid="af2-nutrients-12-01718">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mancone</surname>
<given-names>Massimo</given-names>
</name>
<xref ref-type="aff" rid="af1-nutrients-12-01718">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fedele</surname>
<given-names>Francesco</given-names>
</name>
<xref ref-type="aff" rid="af1-nutrients-12-01718">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1286-467X</contrib-id>
<name>
<surname>Mastroianni</surname>
<given-names>Claudio Maria</given-names>
</name>
<xref ref-type="aff" rid="af2-nutrients-12-01718">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6211-4482</contrib-id>
<name>
<surname>Severino</surname>
<given-names>Paolo</given-names>
</name>
<xref ref-type="aff" rid="af1-nutrients-12-01718">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5921-3180</contrib-id>
<name>
<surname>Ceccarelli</surname>
<given-names>Giancarlo</given-names>
</name>
<xref ref-type="aff" rid="af2-nutrients-12-01718">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Santinelli</surname>
<given-names>Letizia</given-names>
</name>
<xref ref-type="aff" rid="af2-nutrients-12-01718">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0221-6000</contrib-id>
<name>
<surname>Cavarretta</surname>
<given-names>Elena</given-names>
</name>
<xref ref-type="aff" rid="af3-nutrients-12-01718">3</xref>
<xref ref-type="aff" rid="af4-nutrients-12-01718">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Marullo</surname>
<given-names>Antonino G. M.</given-names>
</name>
<xref ref-type="aff" rid="af3-nutrients-12-01718">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2404-3369</contrib-id>
<name>
<surname>Miraldi</surname>
<given-names>Fabio</given-names>
</name>
<xref ref-type="aff" rid="af1-nutrients-12-01718">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6216-9595</contrib-id>
<name>
<surname>Carnevale</surname>
<given-names>Roberto</given-names>
</name>
<xref ref-type="aff" rid="af3-nutrients-12-01718">3</xref>
<xref ref-type="aff" rid="af4-nutrients-12-01718">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nocella</surname>
<given-names>Cristina</given-names>
</name>
<xref ref-type="aff" rid="af1-nutrients-12-01718">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6103-8510</contrib-id>
<name>
<surname>Biondi-Zoccai</surname>
<given-names>Giuseppe</given-names>
</name>
<xref ref-type="aff" rid="af3-nutrients-12-01718">3</xref>
<xref ref-type="aff" rid="af4-nutrients-12-01718">4</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9985-7490</contrib-id>
<name>
<surname>Pagnini</surname>
<given-names>Cristiano</given-names>
</name>
<xref ref-type="aff" rid="af5-nutrients-12-01718">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schiavon</surname>
<given-names>Sonia</given-names>
</name>
<xref ref-type="aff" rid="af3-nutrients-12-01718">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pugliese</surname>
<given-names>Francesco</given-names>
</name>
<xref ref-type="aff" rid="af6-nutrients-12-01718">6</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2703-3761</contrib-id>
<name>
<surname>Frati</surname>
<given-names>Giacomo</given-names>
</name>
<xref ref-type="aff" rid="af3-nutrients-12-01718">3</xref>
<xref ref-type="aff" rid="af7-nutrients-12-01718">7</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3571-5677</contrib-id>
<name>
<surname>d’Ettorre</surname>
<given-names>Gabriella</given-names>
</name>
<xref ref-type="aff" rid="af2-nutrients-12-01718">2</xref>
<xref ref-type="corresp" rid="c1-nutrients-12-01718">*</xref>
</contrib>
</contrib-group>
<aff id="af1-nutrients-12-01718"><label>1</label>Department of Clinical Internal, Anesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, 00185 Rome, Italy; <email>fabio.infusino@uniroma1.it</email> (F.I.); <email>massimo.mancone@uniroma1.it</email> (M.M.); <email>francesco.fedele@uniroma1.it</email> (F.F.); <email>paolo.severino@uniroma1.it</email> (P.S.); <email>fabio.miraldi@uniroma1.it</email> (F.M.); <email>cristina.nocella@uniroma1.it</email> (C.N.)</aff>
<aff id="af2-nutrients-12-01718"><label>2</label>Department of Public Health and Infectious Diseases, Sapienza, University of Rome, 00185 Rome, Italy; <email>massimiliano.marazzato@uniroma1.it</email> (M.M.); <email>claudio.mastroianni@uniroma1.it</email> (C.M.M.); <email>giancarlo.ceccarelli@uniroma1.it</email> (G.C.); <email>letizia.santinelli@uniroma1.it</email> (L.S.)</aff>
<aff id="af3-nutrients-12-01718"><label>3</label>Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, 04100 Latina, Italy; <email>elena.cavarretta@gmail.com</email> (E.C.); <email>antoninogm.marullo@uniroma1.it</email> (A.G.M.M.); <email>roberto.carnevale@uniroma1.it</email> (R.C.); <email>giuseppe.biondizoccai@uniroma1.it</email> (G.B.-Z.); <email>sonia.schiavon@uniroma1.it</email> (S.S.); <email>fraticello@inwind.it</email> (G.F.)</aff>
<aff id="af4-nutrients-12-01718"><label>4</label>Mediterranea Cardiocentro, 80133 Naples, Italy</aff>
<aff id="af5-nutrients-12-01718"><label>5</label>Department of Gastroenterology and Digestive Endoscopy, Azienda Ospedaliera San Giovanni Addolorata, 00184 Rome, Italy; <email>cpagnini@hsangiovanni.roma.it</email></aff>
<aff id="af6-nutrients-12-01718"><label>6</label>Department of General Surgery and Surgical Specialities “Paride Stefanini”, Sapienza, University of Rome, 00185 Rome, Italy; <email>francesco.pugliese@uniroma1.it</email></aff>
<aff id="af7-nutrients-12-01718"><label>7</label>IRCCS NeuroMed, 86077 Pozzilli (IS), Italy</aff>
<author-notes>
<corresp id="c1-nutrients-12-01718"><label>*</label>Correspondence: <email>gabriella.dettorre@uniroma1.it</email>; Tel.: +39-06-4997-9046; Fax: +39-06-4997-9047</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>08</day>
<month>6</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<month>6</month>
<year>2020</year>
</pub-date>
<volume>12</volume>
<issue>6</issue>
<elocation-id>1718</elocation-id>
<history>
<date date-type="received">
<day>30</day>
<month>4</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>6</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© 2020 by the authors.</copyright-statement>
<copyright-year>2020</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>The severe acute respiratory syndrome coronavirus 2 (Sars-CoV-2) global pandemic is a devastating event that is causing thousands of victims every day around the world. One of the main reasons of the great impact of coronavirus disease 2019 (COVID-19) on society is its unexpected spread, which has not allowed an adequate preparation. The scientific community is fighting against time for the production of a vaccine, but it is difficult to place a safe and effective product on the market as fast as the virus is spreading. Similarly, for drugs that can directly interfere with viral pathways, their production times are long, despite the great efforts made. For these reasons, we analyzed the possible role of non-pharmacological substances such as supplements, probiotics, and nutraceuticals in reducing the risk of Sars-CoV-2 infection or mitigating the symptoms of COVID-19. These substances could have numerous advantages in the current circumstances, are generally easily available, and have negligible side effects if administered at the already used and tested dosages. Large scientific evidence supports the benefits that some bacterial and molecular products may exert on the immune response to respiratory viruses. These could also have a regulatory role in systemic inflammation or endothelial damage, which are two crucial aspects of COVID-19. However, there are no specific data available, and rigorous clinical trials should be conducted to confirm the putative benefits of diet supplementation, probiotics, and nutraceuticals in the current pandemic. </p>
</abstract>
<kwd-group>
<kwd>supplementation</kwd>
<kwd>probiotics</kwd>
<kwd>nutraceuticals</kwd>
<kwd>SARS-CoV-2</kwd>
<kwd>COVID-19</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-nutrients-12-01718" sec-type="intro">
<title>1. Introduction</title>
<p>Since its first detection in Wuhan, China, December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had a dramatic worldwide diffusion [<xref ref-type="bibr" rid="B1-nutrients-12-01718">1</xref>]. Accordingly, the World Health Organization (WHO) declared a pandemic on 11 March 2020. The clinical severity spectrum of SARS-CoV-2 may range from asymptomatic cases to severe pneumonia resulting in acute respiratory distress syndrome and sometimes leading to multi organ failure (MOF). More recently, new insights concerning the disease course are emerging. Some patients are initially characterized by dyspnea and hypoxemia, which can rapidly progress to a mild respiratory syndrome needing O<sub>2</sub> therapy. In contrast, other patients rapidly progress to acute respiratory distress syndrome (ARDS), sometimes evolving in septic shock, metabolic acidosis, coagulation dysfunction with disseminated intravascular coagulation (DIC), and multiple organ dysfunction syndrome (MODS). Thus, COVID-19 has emerged as a multifaceted, multi-system, multi-organ disorder which produces its pathogenic effects through a quite ubiquitous target at the level of multiple organs. Notably, all age groups are susceptible to the virus, and elderly patients with comorbidities are more likely to experience a severe illness. As of 29 May 2020, over 5,800,000 confirmed cases have caused more than 360,000 deaths [<xref ref-type="bibr" rid="B2-nutrients-12-01718">2</xref>].</p>
<p>Scientific research efforts are focused on producing a vaccine quickly, because it would be the best way to halt the pandemic. However, despite several groups working on it, it is difficult to guarantee the marketing of a safe product in a short time. Other efforts are actually trying to understand the pathogenesis of COVID-19, which would be extremely useful to identify a specific and more efficient therapy. Although there is no clear clinical evidence for effective antiviral drugs, several antivirals targeting the molecular pathways of SAR-CoV-2 have been used worldwide [<xref ref-type="bibr" rid="B3-nutrients-12-01718">3</xref>], but only remdesivir has shown to be effective in shortening the time to recovery of hospitalized COVID-19 patients [<xref ref-type="bibr" rid="B4-nutrients-12-01718">4</xref>]. Also, a short-term use of corticosteroids to inhibit the cytokine cascade and to prevent disease progression toward a severe form could be considered for patients with severe COVID-19 pneumonia [<xref ref-type="bibr" rid="B5-nutrients-12-01718">5</xref>]. The widely used treatment with chloroquine and hydroxychloroquine (often in association with macrolides) has shown mixed benefits in the available studies and may even be harmful according to some authors, due to cardiac toxicity [<xref ref-type="bibr" rid="B6-nutrients-12-01718">6</xref>,<xref ref-type="bibr" rid="B7-nutrients-12-01718">7</xref>]. Taking into account these results, the WHO firstly suspended the studies launched on chloroquine and hydroxychloroquine [<xref ref-type="bibr" rid="B8-nutrients-12-01718">8</xref>]. Nevertheless, there would seem to be a need for general clarification. Indeed, since several concerns were raised with respect to data and analyses performed at the moment we are proofreading our manuscript the article was retracted and the WHO resumed the studies concerning chloroquine and hydroxychloroquine. In reason of a disproportionate and aberrant immune response able to drive COVID-19 to the related ARDS and, in some patients, to fibrosis and widespread lung damage, tocilizumab, a humanized anti-interleukin-6-receptor (IL-6R) monoclonal antibody that inhibits interleukin-6 (IL-6) signaling, is currently under investigation in several clinical trials [<xref ref-type="bibr" rid="B9-nutrients-12-01718">9</xref>]. </p>
<p>Preliminary data have created interest in anti-cytokine therapy to counteract the inappropriate immune responses as a beneficial therapeutic strategy, and accordingly, the Italian Drug Agency (AIFA, Agenzia Italiana del Farmaco) has also recently approved a clinical trial (Sobi.IMMUNO-101) in which a combination of emapalumab (a monoclonal antibody toward IFN-γ) and anakinra (a recombinant human interleukin-1 receptor antagonist) will be synergistically administrated to COVID-19 patients with the hope to induce a rapid serologic and subsequent clinical improvement.</p>
<p>Besides a pharmacological therapy, many people during this period are wondering if some non-pharmacological substances used to “strengthen their defenses” against common winter infections can be useful. </p>
<p>The pharmacological properties of natural compounds have gained increasing attention in the field of alternative and coadjutant therapeutic approaches to several diseases. Accordingly, the food industry is focused on bioactive substances contained in foods or natural products termed nutraceuticals, which can bring health benefits, besides their intrinsic nutritional values, especially in the treatment of chronic diseases. Moreover, these compounds are characterized by negligible side effects in comparison with traditional pharmacological therapies, so that consumers lean towards their use for health promotion. Regarding the usefulness of non-pharmacological substances, no specific clinical studies for Sars-CoV-2 infection are available yet. However, we will review the possible role of probiotics, nutraceuticals, and diet supplementation in SARS-CoV-2 viral infection. </p>
</sec>
<sec id="sec2-nutrients-12-01718" sec-type="methods">
<title>2. Methods and Design</title>
<p>This scoping review was designed in keeping with the best reviewing practices. Specifically, we searched PubMed for articles on diet supplementation, probiotics, or nutraceuticals for the prevention or treatment of SARS-CoV-2 infection or COVID-19. Specifically, the following string was last run on 16 April 2020: (sars-cov-2 OR covid-19 OR “coronavirus-associated disease 2019”) AND (probiotic* OR nutraceutic* OR diet* OR supplement*). Studies were selected if reporting on original in vitro, in vivo, or human studies, and key study subjects, interventions, and outcomes were systematically collected. All reviewing tasks were performed by two independent reviewers (M. Mancone and P. Severino), with divergences solved after consensus.</p>
</sec>
<sec id="sec3-nutrients-12-01718">
<title>3. Probiotics</title>
<p>Since the first US case of COVID-19 showing atypical symptoms, diarrhea and other gastrointestinal (GI) manifestations have attracted more attention in the scientific community [<xref ref-type="bibr" rid="B10-nutrients-12-01718">10</xref>]. </p>
<p>SARS-CoV-2 infects human cells through the binding of its spike proteins (S) to Angiotensin-Converting-Enzyme-2 (ACE2) [<xref ref-type="bibr" rid="B11-nutrients-12-01718">11</xref>]. ACE2 is highly expressed in AT2 lung cells but also in esophagus epithelial cells and enterocytes in the ileum and colon [<xref ref-type="bibr" rid="B12-nutrients-12-01718">12</xref>]. TMPRSS2, a protein responsible for the priming of the viral S protein (necessary for entry into the host cell) is also highly expressed in absorbent enterocytes [<xref ref-type="bibr" rid="B13-nutrients-12-01718">13</xref>].</p>
<p>SARS-CoV-2 RNA has been detected in the stool of COVID-19 patients [<xref ref-type="bibr" rid="B10-nutrients-12-01718">10</xref>,<xref ref-type="bibr" rid="B14-nutrients-12-01718">14</xref>]. A histological study by Fei Xiao et al. performed on the intestinal mucosa of a patient with stool positivity reported infiltrating plasma cells and lymphocytes with interstitial edema in the epithelium of stomach, duodenum, and rectum. Furthermore, the presence of the viral host receptor ACE2 was demonstrated in the cytoplasm of gastrointestinal epithelial cells, while the viral nucleocapsid protein was visualized in the cytoplasm of rectum, duodenal, and gastric epithelial cells [<xref ref-type="bibr" rid="B15-nutrients-12-01718">15</xref>].</p>
<p>In this last study, GI colonization appeared to be tardive with respect to respiratory infection, and in more than 20% of infected patients, viral RNA was present in stool even after negativization in the respiratory tract. However, this partially contrasts with the report of Wang et al. that showed how the less common GI symptoms like diarrhea, nausea, vomiting, and abdominal discomfort had an early and mild onset compared to the respiratory symptoms [<xref ref-type="bibr" rid="B16-nutrients-12-01718">16</xref>].</p>
<p>Similar evidence from studies on the 2003 first SARS coronavirus epidemic indicated gastrointestinal tropism, since the virus was found in gastrointestinal biopsies and stool, even in healed patients, which may partially justify the intestinal symptoms, reappearance, and transmission of the disease [<xref ref-type="bibr" rid="B17-nutrients-12-01718">17</xref>].</p>
<p>An experimental study on mutant mice with ACE2 deficiency demonstrated the role of this receptor in the regulation of innate immunity, preservation of the gut microbiome, regulation of the intestinal amino acid balance, and production of antimicrobial peptides. These functions were independent from the renin angiotensin system, and transplantation of the altered microbiota from ACE2 mutant mice into germ-free wild-type hosts could increase the propensity for serious colitis [<xref ref-type="bibr" rid="B18-nutrients-12-01718">18</xref>].</p>
<p>Therefore, most of the data suggest that SARS-Cov-2 is more likely transmitted via the respiratory route, but many findings suggest that the intestine could have a relevant role both in the disease pathogenetic evolution and as a possible route of infection. </p>
<p>Based on the intestinal findings, it is possible to assume that viral replication in the intestine determines an exponential increase in the viral load in the digestive mucosa. This mechanism could lead to a loss of barrier integrity with an imbalance of the microbial flora and its metabolites, determining important consequences on the immune system, which could lead to a strong production of cytokines. </p>
<p>This may in part justify the appearance of ARDS and MOF following interstitial pneumonia (<xref ref-type="fig" rid="nutrients-12-01718-f001">Figure 1</xref>).</p>
<p>Classically, viral infections have been considered a bidirectional process involving, exclusively, the host cell and the virus, with no participating external factors other than the host immune system. In the last decade, thanks to the wide knowledge provided by metagenomic analysis, viral infections, like many other medical occurrences, have been associated with the so-called “microbiota revolution”, which is the tendency to link many pathologic conditions to the intestinal microbiota and its alteration. The term “microbiota” refers to the complex community of microorganisms that stably colonize the mucosal surfaces of the human body. Such microbes constitute a key factor in health and disease, because of their essential metabolic and immunomodulatory functions, as well as for their protection against pathogens [<xref ref-type="bibr" rid="B19-nutrients-12-01718">19</xref>,<xref ref-type="bibr" rid="B20-nutrients-12-01718">20</xref>,<xref ref-type="bibr" rid="B21-nutrients-12-01718">21</xref>]. Particularly, commensal bacteria have resulted to play an essential role in shaping the host immune systems as well as in triggering its responses in both health and disease conditions [<xref ref-type="bibr" rid="B22-nutrients-12-01718">22</xref>,<xref ref-type="bibr" rid="B23-nutrients-12-01718">23</xref>]. The presence of an intimate relationship between the host immune system and the microbiota has been primarily evidenced in the gastrointestinal tract by the determination, in germ-free mice, of many immunological defects such as small Peyer’s patches and mesenteric lymph nodes, reduced amount of T helper 17 (Th17) cells, and deficiency in regulatory T cells [<xref ref-type="bibr" rid="B24-nutrients-12-01718">24</xref>]. These defects reverse, within weeks, after the acquisition of intestinal bacteria from normally colonized mice [<xref ref-type="bibr" rid="B25-nutrients-12-01718">25</xref>]. Further evidence has shown that the gastrointestinal tract microbiota is able to modulate neutrophils migration and function [<xref ref-type="bibr" rid="B26-nutrients-12-01718">26</xref>] as well as to influence the differentiation of T cells into Th1, Th2, Th17 helper cells, or T regulatory (Treg) cells [<xref ref-type="bibr" rid="B27-nutrients-12-01718">27</xref>], which may be linked in turn to tolerance or immune reactions against different luminal bacteria. Compared to the study of the intestinal microbiota, that of the lung microbiota is still at the beginning, but some observations support the role played by commensal bacteria in the lung in immune tolerance maintained by subpopulations of alveolar macrophages and dendritic cells [<xref ref-type="bibr" rid="B28-nutrients-12-01718">28</xref>]. Such cell types, by inducing the generation of Tregs [<xref ref-type="bibr" rid="B29-nutrients-12-01718">29</xref>] and releasing prostaglandin E2 (PGE2), tumor growth factor-beta (TGF-β), and interleukin-10 (IL-10) [<xref ref-type="bibr" rid="B28-nutrients-12-01718">28</xref>], exert immunomodulatory functions.</p>
<p>In murine models, the presence of specific bacterial taxa as well as a general increase of bacterial biomass in the lungs has been associated with the development of Treg cells two weeks after birth [<xref ref-type="bibr" rid="B30-nutrients-12-01718">30</xref>], while the introduction of commensal bacteria in germ-free mice has been shown to reduce the strong immune response induced by the intranasal administration of ovalbumin (OVA) [<xref ref-type="bibr" rid="B31-nutrients-12-01718">31</xref>]. In human lungs, bacteria belonging to the phylum Bacteroidetes have been associated with the decrease of lung inflammation [<xref ref-type="bibr" rid="B32-nutrients-12-01718">32</xref>], while the bacterial genera Prevotella and Veillonella have been implicated in Th17 cell-mediated immune responses [<xref ref-type="bibr" rid="B33-nutrients-12-01718">33</xref>].</p>
<p>A synergistic interplay between the microbiota and the human host occurs when the microbial communities are characterized by a balanced state, known as eubiosis. Perturbations of such a condition, called dysbiosis, could lead to the loss and/or the dysregulation of the normal functions provided by the microbiota and constitute a pivotal driver for both infectious and non-infectious diseases [<xref ref-type="bibr" rid="B34-nutrients-12-01718">34</xref>]. To date, a wide range of local and systemic diseases, comprising inflammatory bowel disease, obesity, allergic disorders, atopic dermatitis, autism, colorectal cancer, and diseases affecting both the higher and the lower respiratory tracts, have been associated with microbial dysbiosis [<xref ref-type="bibr" rid="B35-nutrients-12-01718">35</xref>,<xref ref-type="bibr" rid="B36-nutrients-12-01718">36</xref>,<xref ref-type="bibr" rid="B37-nutrients-12-01718">37</xref>,<xref ref-type="bibr" rid="B38-nutrients-12-01718">38</xref>,<xref ref-type="bibr" rid="B39-nutrients-12-01718">39</xref>]. In particular, in recent years, the interaction between the intestine and the respiratory system, both for homeostasis maintenance and in disease pathways, has been individuated, and the term “gut–lung axis” was coined to refer to this mutual interaction [<xref ref-type="bibr" rid="B40-nutrients-12-01718">40</xref>].</p>
<p>Although dysbiosis is often characterized by a multifactorial etiology, one of its main causes is represented by infections carried out by invading pathogens, most commonly by viruses. Studies investigating the interaction between viruses and the microbiota have shown that commensal bacteria, through different mechanisms, are able to regulate or are regulated by invading viruses, thereby leading to harmful or beneficial effects on the host [<xref ref-type="bibr" rid="B41-nutrients-12-01718">41</xref>,<xref ref-type="bibr" rid="B42-nutrients-12-01718">42</xref>,<xref ref-type="bibr" rid="B43-nutrients-12-01718">43</xref>,<xref ref-type="bibr" rid="B44-nutrients-12-01718">44</xref>,<xref ref-type="bibr" rid="B45-nutrients-12-01718">45</xref>]. Consensus has been reached that viral infections, including those sustained by influenza viruses, alter the commensal microbiota in both the gastrointestinal and the airway tracts of the host, causing alterations of the microbiota–host relationship, which is a key element in determining infection-related disease. Different studies have evidenced that, in the upper respiratory tract, the influenza virus infection is associated with decreased colonization by health-promoting bacteria as well as with enrichment in potentially harmful microbes. For example, it has been reported that the nasopharyngeal microbiota of patients with viral respiratory tract infections is significantly enriched in bacterial pathogens such as <italic>Haemophilus influenzae</italic>, <italic>Staphylococcus aureus</italic>, <italic>Streptococcus pneumoniae</italic>, and <italic>Moraxella catarrhalis</italic>, [<xref ref-type="bibr" rid="B46-nutrients-12-01718">46</xref>] while the colonization of the health-associated genus <italic>Prevotella</italic> results to be decreased [<xref ref-type="bibr" rid="B46-nutrients-12-01718">46</xref>,<xref ref-type="bibr" rid="B47-nutrients-12-01718">47</xref>]. Although contradictory findings are reported in the current literature for the gut microbiota, resulting from differences in experimental conditions, concerning virus subtypes and doses, experimental animal models, age, diet, and lifestyle of the investigated subjects, a general decrease in the richness of bacteria belonging to the phylum Firmicutes, mainly <italic>Lactobacilli</italic>, has been associated with viral infections and, in particular, with influenza viruses [<xref ref-type="bibr" rid="B48-nutrients-12-01718">48</xref>,<xref ref-type="bibr" rid="B49-nutrients-12-01718">49</xref>,<xref ref-type="bibr" rid="B50-nutrients-12-01718">50</xref>]. One of the postulated mechanisms leading to influenza-associated commensal microbiota dysregulation involves the altered delivery of IFN-γ (a type II IFN) by a subset of lung-derived T cells expressing CC chemokine receptor 9 in the intestine and the subsequent stimulation of epithelial cells to produce IL-15, which induces a Th17-mediated immune response [<xref ref-type="bibr" rid="B51-nutrients-12-01718">51</xref>]. Although no direct evidence is currently available about the association between SARS-CoV-2 infections and microbial dysbiosis in both the gut and the respiratory tract, the presence of symptoms like diarrhea, nausea, vomiting, and abdominal discomfort, as well as the determined tropism of SARS-CoV-2 for enterocytes [<xref ref-type="bibr" rid="B14-nutrients-12-01718">14</xref>,<xref ref-type="bibr" rid="B15-nutrients-12-01718">15</xref>,<xref ref-type="bibr" rid="B52-nutrients-12-01718">52</xref>], suggests that interactions between this new β-coronavirus and the gut microbiota are possible.</p>
<p>To date, while effective therapies or vaccines to prevent and fight respiratory virus infections are available for influenza and adenoviruses, no effective therapies are available for other respiratory viruses such as those responsible for common cold and the new β-coronavirus SARS-CoV-2. The need to rapidly contrast respiratory viral infections together with the large amount of time and money necessary for the development of vaccines challenge the development of alternative and safe therapies able to reduce the risk of such infections. In this context, the use of probiotics could represent a promising tool in the field of clinical research. Probiotics consist of alive organisms that, when administered in sufficient amounts, confer positive benefits to patients, and their potential clinical utilization has been proposed in numerous pathologic conditions [<xref ref-type="bibr" rid="B53-nutrients-12-01718">53</xref>]. Although solid evidence is still lacking, many experimental and clinical studies support the possible role of different probiotic microorganisms in protecting the host against viral infections, comprising those responsible for colds and flu [<xref ref-type="bibr" rid="B54-nutrients-12-01718">54</xref>,<xref ref-type="bibr" rid="B55-nutrients-12-01718">55</xref>,<xref ref-type="bibr" rid="B56-nutrients-12-01718">56</xref>,<xref ref-type="bibr" rid="B57-nutrients-12-01718">57</xref>,<xref ref-type="bibr" rid="B58-nutrients-12-01718">58</xref>,<xref ref-type="bibr" rid="B59-nutrients-12-01718">59</xref>].</p>
<p>A recent Cochrane meta-analysis, including 12 randomized controlled trials (RCT) with a total of 3720 subjects, demonstrated that probiotics were able to reduce the number of acute upper respiratory tract infections, the mean duration of disease, antibiotic administration, and cold-related school absences compared to a placebo, although the quality of evidence was low [<xref ref-type="bibr" rid="B60-nutrients-12-01718">60</xref>].</p>
<p>The exact mechanism(s) of the antiviral activity of probiotics is not completely clear and it likely involves multiple concomitant steps. In particular, the potential therapeutic effect of probiotic bacteria against viral infections could be exerted at three different levels implicating a direct interaction with the virus: (1) by reinforcing the mucosal innate immune response; (2) by reducing intestinal permeability; and (3) by affecting the systemic acquired immune response through a regulatory and anti-inflammatory effect.</p>
<p>Virus attachment to a host cell represent an essential step in viral infection, so probiotic bacteria may inhibit it by directly binding the virus, thus inhibiting the infectious process. It has been reported that lactobacilli are able to bind and inactivate viruses through adsorptive and/or trapping mechanisms. Bacterial strains of <italic>Lactobacillus paracasei</italic>, <italic>Lactobacillus rhamnosus</italic>, as well as <italic>Lactobacillus plantarum</italic> can interact with the envelop of vesicular stomatitis virus (VSV), directly trapping the virus [<xref ref-type="bibr" rid="B61-nutrients-12-01718">61</xref>]. An inhibiting mechanism involving a direct interaction between bacterial cell wall components and herpes simplex virus type 2 has been also suggested for <italic>Lactobacillus brevis</italic> CD2 strain [<xref ref-type="bibr" rid="B62-nutrients-12-01718">62</xref>]. Furthermore, exopolysaccharides from <italic>Lactobacillus</italic> species were demonstrated to completely suppress the production of adenovirus-5 in vitro [<xref ref-type="bibr" rid="B63-nutrients-12-01718">63</xref>].</p>
<p>Lactobacilli, as well as other probiotics, have been reported to possess an immunomodulatory ability and protect from virus infections by enhancing cytokine antiviral responses in respiratory and immune cells and in the intestinal mucosa [<xref ref-type="bibr" rid="B63-nutrients-12-01718">63</xref>,<xref ref-type="bibr" rid="B64-nutrients-12-01718">64</xref>,<xref ref-type="bibr" rid="B65-nutrients-12-01718">65</xref>,<xref ref-type="bibr" rid="B66-nutrients-12-01718">66</xref>,<xref ref-type="bibr" rid="B67-nutrients-12-01718">67</xref>]. Oral administration of <italic>L. brevis</italic> in mice protected the animals from influenza infection through the enhancement of antiviral IFN-α as well as an augmented production of specific-IgA antibodies against the virus [<xref ref-type="bibr" rid="B68-nutrients-12-01718">68</xref>]. <italic>L. plantarum</italic> significantly reduced the titers of human H1N1 and avian influenza H7N9 viruses in mouse lungs after a lethal viral challenge and increased the mean number of days and rates of survival of the infected mice [<xref ref-type="bibr" rid="B69-nutrients-12-01718">69</xref>].</p>
<p>Interestingly, intranasal administration of lactobacilli showed to be protective against virus respiratory infections, encouraging innate immune responses directly in the airway epithelium [<xref ref-type="bibr" rid="B70-nutrients-12-01718">70</xref>]. In addition, <italic>L. paracasei</italic>-fed mice showed a lower incidence of influenza A H3N2 infection, associated with a reduced infiltration of inflammatory cells in the lungs and a faster virus elimination [<xref ref-type="bibr" rid="B71-nutrients-12-01718">71</xref>]. Bacteria belonging to the <italic>Bifidobacteria</italic> group exert protective effects against influenza virus infection. After lethal influenza A (H1N1) infection, a strong stimulation of humoral and cellular immunity, associated with lower levels of proinflammatory IL-6 production and an increase in survival rate of mice receiving <italic>Bifidobacterium bifidum,</italic> with respect to the control group, was observed [<xref ref-type="bibr" rid="B72-nutrients-12-01718">72</xref>]. Another important preventive action of probiotics against the progression of viral infections could be mediated by the enhancement of the mucosal intestinal barrier that in turn may prevent virus spreading in the sub-mucosal compartment and in the systemic circulation. A multi-strain probiotic mixture has demonstrated a preventive effect on intestinal inflammation onset in a mouse model of spontaneous ileitis, mediated by the stimulation of TNF release from epithelial cells and decreased permeability [<xref ref-type="bibr" rid="B73-nutrients-12-01718">73</xref>,<xref ref-type="bibr" rid="B74-nutrients-12-01718">74</xref>]. <italic>L. rhamnosus</italic> GG has shown a beneficial effect in the treatment of infections by enhancing intestinal permeability, with the stimulation of mucin expression and the regulation of proliferation/apoptosis of epithelial cells, both in experimental models and in clinical studies [<xref ref-type="bibr" rid="B75-nutrients-12-01718">75</xref>,<xref ref-type="bibr" rid="B76-nutrients-12-01718">76</xref>].</p>
<p>An interesting antiviral activity exerted by probiotics is related to their ability to modulate the immune system towards anti-inflammatory pathways. <italic>Lactobacillus gasseri</italic> exhibits antiviral activity against respiratory syncytial virus (RSV); in fact, oral administration of this probiotic in mice causes a reduction of the RSV titer in the lungs. Moreover, the expression of pro-inflammatory mediators in the lungs due to RSV infection decreased, while interferon-stimulated genes were upregulated by <italic>L. gasseri</italic> treatment [<xref ref-type="bibr" rid="B77-nutrients-12-01718">77</xref>]. A reduction of virus-induced inflammation was also exerted by a strain of <italic>L. plantarum</italic> in mice after acute infection by pneumonia virus (PMV), a rodent pathogen that induces inflammation and is related to the respiratory syncytial virus [<xref ref-type="bibr" rid="B78-nutrients-12-01718">78</xref>]. <italic>Bifidobacterium animalis</italic> subspecies <italic>lactis</italic> Bl-04, in an experimental rhinovirus infection, showed to reduce the levels of the pro-inflammatory cytokine IL-6, as well as to reduce the nasal lavage virus titer [<xref ref-type="bibr" rid="B79-nutrients-12-01718">79</xref>]. Similarly, the administration of this probiotic in the respiratory tract of mice infected with PVM, increased mice survival and reduced the levels of IL-6, whose suppression was demonstrated to be a critical feature of the protective mechanism. It was recently reported that COVID-19, similarly to SARS-CoV, is characterized by a dramatic inflammatory response induced by a cytokine storm associated with increased disease severity [<xref ref-type="bibr" rid="B80-nutrients-12-01718">80</xref>,<xref ref-type="bibr" rid="B81-nutrients-12-01718">81</xref>]. Patients needing intensive care present higher plasma levels of many cytokines such as IL-6, IL-1, IP-10, MCP-1, MIP-1A, and TNFα [<xref ref-type="bibr" rid="B82-nutrients-12-01718">82</xref>] with respect to non- intensive care unit (ICU) subjects, suggesting the likely involvement of a highly pro-inflammatory condition in the disease progression and severity. Furthermore, a large infiltration of inflammatory cells has been observed in the lungs of severe COVID-19 patients [<xref ref-type="bibr" rid="B83-nutrients-12-01718">83</xref>,<xref ref-type="bibr" rid="B84-nutrients-12-01718">84</xref>]. These aberrant pathogenic cells, together with inflammatory monocytes, may reach the lungs, causing an immune injury with consequent respiratory disability and increased mortality. The modulation of the cytokine cascade exerted by probiotics may represent a therapeutic approach for severe infections, making it licit to hypothesize that probiotics administration could influence the immune response in patients affected by COVID-19, thus preventing or mitigating the exacerbated inflammatory processes that lead to death.</p>
<p>Although solid evidence for probiotics utilization in the treatment of COVID-19 is still lacking, their complementary use may be proposed, as already stated by China’s National Health Commission and National Administration of Traditional Chinese Medicine in the “Diagnostic and therapeutic guidance for 2019 novel coronavirus disease (version5)” [<xref ref-type="bibr" rid="B85-nutrients-12-01718">85</xref>]. In particular, probiotic supplementation was suggested as a complementary treatment of gastrointestinal symptoms such as diarrhea and to reduce the risk of secondary infections due to microbial translocation in severe COVID-19 cases [<xref ref-type="bibr" rid="B86-nutrients-12-01718">86</xref>]. Despite the fact that direct evidence of the possible effect of probiotics on SARS-CoV-2 infection is not available [<xref ref-type="bibr" rid="B87-nutrients-12-01718">87</xref>], a number of suggestions indicate that this resource could represent a complementary tool to decrease SARS-CoV-2-related inflammation and favor the recovery of intestinal mucosa damage by modulating the gut microbiota. In fact, recent studies suggest that SARS-CoV-2 induces an acute intestinal inflammatory response via ACE2 and transmembrane serine protease 2, characterized by mucosal infiltration of macrophages, neutrophils, and T-cells. [<xref ref-type="bibr" rid="B88-nutrients-12-01718">88</xref>]. For these reasons, probiotic use could have a beneficial role in patients with COVID-related gastro-intestinal symptoms and in those with mild–moderate systemic symptoms without respiratory impairment and help prevent disease progression. As speculated, it is possible that probiotics may play a role in preventing the cytokine storm and related ARDS or MOF in high-risk individuals with established SARS-CoV-2 infection, but the opposite may also be true, and the lack of sufficient available evidence should be considered. Similarly, in patients with severe disease and in critically ill patients, probiotic administration needs to be cautiously evaluated, and important safety concerns need to be considered when administering bacterial supplements [<xref ref-type="bibr" rid="B89-nutrients-12-01718">89</xref>]. In fact, it is not known whether the administration of micro-organisms to patients with critical disease conditions could lead to any type of injury, such as an exacerbation of inflammation. A final possible setting is disease prevention, especially for high-risk patients (immunosuppressed and elderly patients with comorbidities), “strategic” people (i.e., health care professionals, workers with extensive public contact), or subjects with suspected COVID-19 waiting for a clear diagnosis and/or who came in contact with a COVID-19-positive subject. The rationale for the possible prophylactic use of probiotics in SARS-CoV2 infection is linked to its ability to preserve a healthy status in the gut-associated lymphoid tissue (GALT) as well as eubiosis, which is necessary to actively fight the entry of the virus into gut cells [<xref ref-type="bibr" rid="B90-nutrients-12-01718">90</xref>]. The enhancement of the innate defenses may be probably useful in COVID-19 prevention or in the very early phase of the infection. However, it is not known whether the administration of various types of microorganisms to healthy individuals can increase the risk of contracting SARS-CoV-2 infection. Large clinical trials are needed to elucidate these hot topics and identify the most useful and safe setting for probiotics administration. Actually, three registered trials to evaluate probiotics administration to COVID-19 patients are ongoing (<xref ref-type="table" rid="nutrients-12-01718-t001">Table 1</xref>).</p>
</sec>
<sec id="sec4-nutrients-12-01718">
<title>4. Nutraceuticals</title>
<p>Chronic respiratory diseases are associated with the development of systemic inflammation and oxygen stress resulting in endothelial dysfunction together with increased platelet aggregation and enhanced coagulation. All these factors are involved in the pathophysiology of respiratory diseases, leading to irreversible endothelial dysfunction [<xref ref-type="bibr" rid="B94-nutrients-12-01718">94</xref>].</p>
<p>It has been previously demonstrated that patients with community-acquired pneumonia (CAP), the most common infection-related cause of death in developed countries, display increased platelet activation mediated by the activation of NOX2, the main enzymatic source of cellular reactive oxygen species (ROS) production, with consequent decrease of flow-mediated dilation (FMD) and NO bioavailability [<xref ref-type="bibr" rid="B94-nutrients-12-01718">94</xref>,<xref ref-type="bibr" rid="B95-nutrients-12-01718">95</xref>,<xref ref-type="bibr" rid="B96-nutrients-12-01718">96</xref>]. Moreover, these patients disclose an ongoing pro-thrombotic state, as suggested by increased plasma levels of F1+2, a marker of thrombin generation, and lower levels of protein C (PC) and activated PC (aPC) [<xref ref-type="bibr" rid="B94-nutrients-12-01718">94</xref>,<xref ref-type="bibr" rid="B95-nutrients-12-01718">95</xref>].</p>
<p>In severe forms of COVID-19, it has been proposed that a severe widespread alveolar and interstitial inflammation extends to the pulmonary vasculature. Intra-pulmonary inflammation might negatively modulate a severe local vascular dysfunction including micro-thrombosis and hemorrhage, resulting in pulmonary intravascular coagulopathy (PIC).</p>
<p>Accordingly, the reduced endothelial function, that is an early subclinical stage of vascular alteration, could favor the development of a severe form of this pathology, contributing to increased pulmonary, cardiovascular, and renal complications.</p>
<p>The immune system is the second system most affected by COVID-19 after the respiratory system. An increase in systemic interleukins, chemokines, and tumor necrosis factor-α (TNF-α) has been observed during the rapid progression phase of COVID-19 [<xref ref-type="bibr" rid="B80-nutrients-12-01718">80</xref>]. These changes correspond to the characteristics of a cytokine release syndrome (CRS) in which IL-6 contributes to many of the key symptoms. The role of IL-6 in COVID-19 patients has been highlighted in a recent retrospective multicenter study [<xref ref-type="bibr" rid="B97-nutrients-12-01718">97</xref>] showing that circulating IL-6 levels were higher in COVID-19 deceased patients compared to discharged subjects. These results suggest that the “cytokine storm syndrome”, activated by the virus could be a clinical predictor of fatal outcome in these patients. The activation of endothelial cells and the ensuing vascular dysfunction are other typical features of severe CRS. Indeed, typical markers of endothelial activation are often elevated in the serum of patients with CRS. This indicates that the endothelium plays an important role in the pathophysiology of CRS, both by amplifying the inflammatory response and by contributing to clotting and eventually to a thrombotic disease, both in the venous and in the arterial circulations [<xref ref-type="bibr" rid="B98-nutrients-12-01718">98</xref>].</p>
<p>In addition to the inflammatory process, the mechanisms accounting for clotting and vascular changes may also include oxidative stress. In particular, NOX2-derived ROS are implicated in clotting and platelet activation, promoting thrombin generation and platelet aggregation or impairing artery dilatation.</p>
<p>Thus, oxidative stress and inflammation are closely interrelated and form a vicious feed-forward cycle during atherogenetic plaque progress. Indeed, according to the oxidative stress theory of atherosclerosis, the progression of the atherosclerotic plaque, with plaque rupture, clotting, and ensuing atherothrombosis, is dependent upon artery inflammation [<xref ref-type="bibr" rid="B99-nutrients-12-01718">99</xref>].</p>
<p>Based on these considerations, nutraceuticals, defined as substances that may include isolated nutrients, dietary supplements, diets, and herbal products, could play a role in preventing the phenomena of the inflammatory cascade and hypercoagulation by exerting their anti-inflammatory and antioxidant activities. Among nutraceuticals, vitamin E, vitamin C, carotenoids, and some minerals (Zn, Mn, Cu, Se) and polyphenols (flavonoids, phenolic acids, stilbenes, lignans) provide medical or health benefits by a synergistic effect, maintaining a proper redox homeostasis (<xref ref-type="fig" rid="nutrients-12-01718-f002">Figure 2</xref>)</p>
<p>In particular, a diet rich in polyphenols is able to reduce and prevent cardiovascular disease. [<xref ref-type="bibr" rid="B100-nutrients-12-01718">100</xref>]. Moreover, the protective effect of polyphenols includes the reduction of oxidative stress resulting from the downregulation of NADPH oxidase or from an antiplatelet and anticoagulant function, as indicated by the reduction of platelet aggregation and the suppression of the activity of thrombin and the production of factor Xa [<xref ref-type="bibr" rid="B101-nutrients-12-01718">101</xref>,<xref ref-type="bibr" rid="B102-nutrients-12-01718">102</xref>]. Moreover, flavonoids could increase endogenous platelet-derived nitric oxide and decrease superoxide production [<xref ref-type="bibr" rid="B103-nutrients-12-01718">103</xref>] and might enhance the endothelial synthesis of NO, induce NO-dependent relaxation in isolated arteries, and activate NO signaling pathways in endothelial cells, thus improving the endothelial function. Finally, some polyphenols exert anti-inflammatory activities by modulating cytokine production and by promoting the expression of pro-inflammatory genes [<xref ref-type="bibr" rid="B104-nutrients-12-01718">104</xref>], and an antiviral effect that has been already reported against several viruses [<xref ref-type="bibr" rid="B105-nutrients-12-01718">105</xref>].</p>
<p>Given this premise, it is reasonable to consider oxidative stress- and inflammation-mediated endothelial dysfunction as a therapeutic target for Covid-19. Among polyphenols, curcumin could be a potential treatment option for patients with Covid-19. Utomo et al. conducted a study using molecular docking with target receptors including SARS-CoV-2 protease, the receptor binding domain (RBD) of spike glycoprotein, and the protease domain (PD) of ACE2 which are believed to participate in virus infection [<xref ref-type="bibr" rid="B106-nutrients-12-01718">106</xref>]. They demonstrated that curcumin could bind to the target receptors of SARS-CoV-2, supporting the use of this molecule for preventive or prophylaxis treatments of virus infections, including SARS-CoV-2. Moreover, a combination of three (phyto-) nutrients such as vitamin C, curcumin, and glycyrrhizic acid promotes interferons production and regulates the inflammatory response, suggesting that the combination of these molecules may be helpful in regulating the immune response to combat SARS-CoV-2 infections [<xref ref-type="bibr" rid="B107-nutrients-12-01718">107</xref>].</p>
<p>Finally, Runfeng et al. tested in vitro the antiviral activity of Lianhuaqingwen (LH), a Chinese patent nutraceutical composed of 13 herbs [<xref ref-type="bibr" rid="B108-nutrients-12-01718">108</xref>], and they found that LH is able to inhibit SARS-CoV-2 virus replication and markedly reduce the mRNA levels of pro-inflammatory cytokines including TNF-α, IL-6, CCL-2/MCP-1, and CXCL-10/IP-10).</p>
<p>In conclusion, since accumulating evidence suggests that nutraceuticals exert beneficial effects against vascular diseases counteracting oxidative stress and inflammation, it is reasonable to speculate their possible use in the setting of COVID-19.</p>
<p>Regarding the illustrated inflammatory hypothesis, new recent considerations on TNF blockers deserve a mention. Further promising and potentially effective therapies for COVID-19 are the anti-TNF antibodies infliximab and adalimumab, which have also shown a good safety profile [<xref ref-type="bibr" rid="B109-nutrients-12-01718">109</xref>]. The rationale of their use is related to the demonstrated presence of TNF in the serum and in some tissues of COVID-19 patients, where it promotes a phlogistic response [<xref ref-type="bibr" rid="B110-nutrients-12-01718">110</xref>]. For several inflammatory diseases, anti-TNF therapies are approved by the FDA and commonly used (e.g., rheumatoid arthritis or psoriasis). Studies on rheumatoid arthritis have shown that blocking TNF stops the cytokine cascade, decreasing the levels of adhesion molecules and vascular endothelial growth factor (VEGF) involved in the pathways of augmented vascular permeability [<xref ref-type="bibr" rid="B111-nutrients-12-01718">111</xref>,<xref ref-type="bibr" rid="B112-nutrients-12-01718">112</xref>]. Also, some preclinical studies on RSV and influenza virus in mice suggest a positive response to anti-TNF therapies [<xref ref-type="bibr" rid="B113-nutrients-12-01718">113</xref>]. Some authors suggested that infliximab or adalimumab administration could be preferentially destinated to COVID-19 patients with moderate disease but at high risk to develop a severe and advanced illness [<xref ref-type="bibr" rid="B109-nutrients-12-01718">109</xref>,<xref ref-type="bibr" rid="B114-nutrients-12-01718">114</xref>]. Actually, a single registered RCT evaluating adalimumab for COVID-19 treatment is in progress (ChiCTR2000030089). Main nutraceuticals and supplements with potential role in countering COVID-19 are listed in <xref ref-type="table" rid="nutrients-12-01718-t002">Table 2</xref>.</p>
</sec>
<sec id="sec5-nutrients-12-01718">
<title>5. Supplementation</title>
<sec id="sec5dot1-nutrients-12-01718">
<title>5.1. Vitamin C</title>
<p>Vitamin C is a water-soluble vitamin able to provide electrons, acting as antioxidant and as a cofactor for regulatory enzymes. In particular, it facilitates the production of cortisol, catecholamines, and vasopressin. Vitamin C is fundamental for both the innate and the adaptive immune system. Vitamin C has a role in the epithelial as well as endothelial barrier function, maintains vasodilation, and reduces proinflammatory modulators [<xref ref-type="bibr" rid="B115-nutrients-12-01718">115</xref>]. Vitamin C has crucial roles in the improvement of phagocytosis, chemotaxis, and production of ROS, decreasing necrosis and tissue damage [<xref ref-type="bibr" rid="B116-nutrients-12-01718">116</xref>].</p>
<p>The role of ascorbic acid in modulating the immune system has been studied extensively since the second half of the last century. As early as 1978, a study by J.G. Atherton et al. showed increased resistance of chicken respiratory epithelium cultures to infection by a Coronavirus (avian infectious bronchitis virus) after exposure to Vitamin C. However, this animal virus does not share the receptor and pathway with SARS-Cov-2, for which there is no specific evidence regarding potential Vitamin C benefits [<xref ref-type="bibr" rid="B117-nutrients-12-01718">117</xref>].</p>
<p>In humans, supplementation of vitamin C improves the immune system, preserving the redox integrity of cells as well as protecting from ROS. Vitamin C reduces the risk, the severity, and the duration of different infectious diseases [<xref ref-type="bibr" rid="B118-nutrients-12-01718">118</xref>,<xref ref-type="bibr" rid="B119-nutrients-12-01718">119</xref>].</p>
<p>Vitamin C deficiency was historically associated with pneumonia [<xref ref-type="bibr" rid="B120-nutrients-12-01718">120</xref>,<xref ref-type="bibr" rid="B121-nutrients-12-01718">121</xref>]. On the other hand, randomized trials demonstrated that supplementation of vitamin C has positive effects on symptoms and on the duration of respiratory tract infections. Additionally, several data suggest that vitamin C can prevent pneumonia and improve its outcome, as well as other infections [<xref ref-type="bibr" rid="B122-nutrients-12-01718">122</xref>,<xref ref-type="bibr" rid="B123-nutrients-12-01718">123</xref>,<xref ref-type="bibr" rid="B124-nutrients-12-01718">124</xref>,<xref ref-type="bibr" rid="B125-nutrients-12-01718">125</xref>].</p>
<p>Moreover, it has been shown that intravenous vitamin C may reduce inflammation and diminish vascular injury associated with sepsis and ARDS [<xref ref-type="bibr" rid="B126-nutrients-12-01718">126</xref>,<xref ref-type="bibr" rid="B127-nutrients-12-01718">127</xref>]. Studies on lung injury induced by sepsis showed that vitamin C reduces the proinflammatory and procoagulant changes that lead to lung damage [<xref ref-type="bibr" rid="B126-nutrients-12-01718">126</xref>]. Moreover, during infection, vitamin C levels can decrease; therefore, high doses of intravenous Vitamin C administration are required in severe cases, in order to compensate for the high turnover of the vitamin [<xref ref-type="bibr" rid="B128-nutrients-12-01718">128</xref>].</p>
<p>However, studies on the usefulness of vitamin C for patients with severe pneumonia are limited [<xref ref-type="bibr" rid="B129-nutrients-12-01718">129</xref>]. A retrospective before–after clinical study showed that a combination of vitamin C, hydrocortisone, and thiamine prevented organ dysfunction and reduced the mortality rate in patients with sepsis [<xref ref-type="bibr" rid="B130-nutrients-12-01718">130</xref>]. Treatment with the same combination was associated with significantly lower mortality in patients with severe pneumonia and significantly improved their radiologic chest findings [<xref ref-type="bibr" rid="B131-nutrients-12-01718">131</xref>]. Vitamin C and corticosteroids play in a synergistic way: vitamin C restores glucocorticoid receptor function, and corticosteroids increase the expression of sodium–vitamin C transporter-2 [<xref ref-type="bibr" rid="B132-nutrients-12-01718">132</xref>,<xref ref-type="bibr" rid="B133-nutrients-12-01718">133</xref>] Moreover, an experimental study showed that vitamin C and hydrocortisone administered together preserved endothelial integrity [<xref ref-type="bibr" rid="B134-nutrients-12-01718">134</xref>]. In a recent randomized trial, evaluating patients with sepsis and ARDS, a beneficial effect of high-dose intravenous vitamin C on mortality has been suggested, although no improvement of organ dysfunction scores or change in markers of inflammation and vascular injury were observed [<xref ref-type="bibr" rid="B135-nutrients-12-01718">135</xref>,<xref ref-type="bibr" rid="B136-nutrients-12-01718">136</xref>,<xref ref-type="bibr" rid="B137-nutrients-12-01718">137</xref>]. Moreover, recently, a new clinical trial to investigate the effects of vitamin C infusion for the treatment of severe COVID-19 pneumonia has started [<xref ref-type="bibr" rid="B138-nutrients-12-01718">138</xref>]. In fact, in the absence of a specific therapy for COVID-19, vitamin C may have effects on this severe viral respiratory tract infection [<xref ref-type="bibr" rid="B139-nutrients-12-01718">139</xref>]. Moreover, vitamin C increased the resistance to coronavirus and may affect the susceptibility to lower respiratory tract infections under certain conditions [<xref ref-type="bibr" rid="B117-nutrients-12-01718">117</xref>,<xref ref-type="bibr" rid="B139-nutrients-12-01718">139</xref>,<xref ref-type="bibr" rid="B140-nutrients-12-01718">140</xref>,<xref ref-type="bibr" rid="B141-nutrients-12-01718">141</xref>].</p>
</sec>
<sec id="sec5dot2-nutrients-12-01718">
<title>5.2. Vitamin D</title>
<p>The biosignaling role of vitamin D in bone metabolism is well known, but over the years, this metabolite has been linked to the risk of developing various pathologies, such as cancer, depression, and infectious diseases. After binding its nuclear receptor, the active metabolite of vitamin D (1,25(OH)2D3 or calcitriol) influences gene transcription, exerting several effects also on the immune and inflammatory response. As recently summarized in a review by Grant et al., Vitamin D would act against respiratory infections through many pathways [<xref ref-type="bibr" rid="B142-nutrients-12-01718">142</xref>]. The receptor for vitamin D is expressed in respiratory epithelial cells and in macrophages of the respiratory system; furthermore, the 25- hydrolase, which converts vitamin D into its active metabolite, is constitutively expressed in the respiratory epithelium [<xref ref-type="bibr" rid="B143-nutrients-12-01718">143</xref>]. The in vitro study of Philip et al. showed that in the presence of 1,25(OH)2D3, macrophagic production of catelicidine (like LL-37) is increased. By binding the envelope of influenza A and respiratory syncytial viruses, catelicidins are capable to damage its structure and prevent infection of human cells [<xref ref-type="bibr" rid="B144-nutrients-12-01718">144</xref>].</p>
<p>Much evidence has also suggested that other biosignaling pathways linked to vitamin D may modulate the inflammatory response depending on both the innate and specific systems. In fact, 1,25(OH)2D3 modulates nuclear factor κB (NF-kB) activity via upregulation of the NF-κB inhibitory protein (IκBα). NF-kB induces the production of many molecules which amplify the inflammatory response (IL-6, IL1-β, TNF-α), stimulate the production, mobilization, and adhesion of inflammatory cells (GM-CSF, IL-4, IL-5, VCAM-1, ICAM-1, E-selectin), and finally influence the production of enzymes such as iNOS, COX-2, PLA2 and determine the production of free radicals causing tissue damage [<xref ref-type="bibr" rid="B145-nutrients-12-01718">145</xref>,<xref ref-type="bibr" rid="B146-nutrients-12-01718">146</xref>].</p>
<p>There are many other molecular mechanisms through which vitamin D would be able to stimulate the immune response, reduce the risk of infections, and balance the inflammatory reaction probably in a favorable way for the body. The study of the clinical effects of vitamin D administration in patients with and without demonstrated vitamin D deficiency could be very interesting today in the setting of COVID-19; however, specific data are not yet available.</p>
<p>In the analysis of Monlezun et al. evaluating 14,108 subjects (&gt;16 years of age), after adjusting for confounding factors like season or demographic and clinical data, vitamin D levels &lt;30 ng/mL were associated with 58% higher odds of acute respiratory infection compared to levels ≥30 ng/mL [<xref ref-type="bibr" rid="B147-nutrients-12-01718">147</xref>].</p>
<p>A meta-analysis of data of 10,933 participants from 25 randomized controlled trials showed that vitamin D administration reduces the risk of acute respiratory tract infections (OR 0.88, 0.81 to 0.96; P for heterogeneity &lt;0.001). In subgroup analysis, protective effects were obtained for participants assuming daily or weekly doses with no supplemental bolus (OR 0.81, 0.72 to 0.91) but not for subjects assuming one or more boli (OR 0.97, 0.86 to 1.10; P for interaction = 0.05). Regarding the daily or weekly administration of vitamin D, benefits were more evident in participants with low calcifediol levels (&lt;25 nmol/L) at baseline (OR 0.30, 0.17 to 0.53) than in subjects with initial levels ≥25 nmol/L (OR 0.75, 0.60 to 0.95; P for interaction = 0.006). Finally, the administration of vitamin D was safe [<xref ref-type="bibr" rid="B148-nutrients-12-01718">148</xref>].</p>
<p>The hypothesis that vitamin D supplementation can reduce the risk of COVID-19 incidence or mortality should be investigated through large-scale randomized trials. Currently, no data are available on the dosage, method of administration (daily or bolus), and safety in the setting of COVID-19; however, for the moment it is reasonable to focus on the identification and treatment of deficiencies in asymptomatic subjects as well as in patients affected by COVID-19. An Italian study group has proposed a nutritional protocol for patients with COVID-19, which also includes the supplementation of 25-hydroxyvitamin D in the presence of a deficit [<xref ref-type="bibr" rid="B149-nutrients-12-01718">149</xref>].</p>
</sec>
</sec>
<sec id="sec6-nutrients-12-01718" sec-type="conclusions">
<title>6. Conclusions</title>
<p>Although orally administered probiotics are not currently an integral part of a specific protocol for the treatment of respiratory viral infections, many studies suggest their potential modulation of the systemic immune system that can improve the response to viruses and balance the inflammatory response. SARS-CoV-2 infects the gastrointestinal tract, causing inflammation of the absorbent mucosa and sometimes diarrhea. Dysbiosis could participate in this scenario, exacerbating the immune response and the production of systemic inflammation mediators. Based on the revised evidence, oral probiotics could therefore play a role in the intestinal and systemic effects of COVID-19. Moreover, inhaled microorganisms could have a more direct action on the respiratory epithelium and on the immune system cells that populate it. In some circumstances, they have been shown to reduce the accumulation of inflammatory cells and facilitate virus clearance. Several nutrients have shown utility in preserving endothelial integrity thanks to the maintenance of oxidative–reductive homeostasis. COVID-19 can induce pulmonary vascular damage and systemic hypercoagulability. During the pandemic, as in all other circumstances, it is reasonable to recommend a proper nutrition rich in antioxidant nutrients. Vitamin C and D play a well-proven role in the immune system. However, it is not known whether a supplemental dose of these vitamins administered to patients without their deficiency would result in a benefit. Specific clinical studies are underway on the intra-venous administration of vitamin C in hospitalized COVID-19 patients. Vitamin D deficiency has been associated with increased susceptibility to respiratory infections, therefore it is reasonable, even in the absence of specific data, to administer vitamin D to healthy individuals and COVID-19 patients.</p>
<p>While diet, nutritional supplements, and similar interventions show great promise for preventing and managing COVID-19, it is also true that strong clinical research data are required to support any such claim. Otherwise, we risk the emergence of gurus or other more or less well-meaning experts aiming at speculating on the appeal of these interventions for laypersons [<xref ref-type="bibr" rid="B150-nutrients-12-01718">150</xref>].</p>
</sec>
</body>
<back>
<notes>
<title>Funding</title>
<p>This research received no external funding.</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflict of interest.</p>
</notes>
<ref-list>
<title>References</title>
<ref id="B1-nutrients-12-01718">
<label>1.</label>
<element-citation publication-type="web">
<article-title>WHO COVID-19 Dashboard</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://who.sprinklr.com/">https://who.sprinklr.com/</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2020-04-13">(accessed on 13 April 2020)</date-in-citation>
</element-citation>
</ref>
<ref id="B2-nutrients-12-01718">
<label>2.</label>
<element-citation publication-type="web">
<article-title>COVID-19 Map Johns Hopkins Coronavirus Resource Center</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://coronavirus.jhu.edu/map.html">https://coronavirus.jhu.edu/map.html</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2020-04-19">(accessed on 19 April 2020)</date-in-citation>
</element-citation>
</ref>
<ref id="B3-nutrients-12-01718">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19</article-title>
<source/>New. Engl. J. Med.
          <year>2020</year>
<pub-id pub-id-type="doi">10.1056/NEJMoa2001282</pub-id>
<pub-id pub-id-type="pmid">32187464</pub-id>
</element-citation>
</ref>
<ref id="B4-nutrients-12-01718">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beigel</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Tomashek</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Dodd</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Zingman</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Kalil</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Hohmann</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>H.Y.</given-names>
</name>
<name>
<surname>Luetkemeyer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kline</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Remdesivir for the Treatment of Covid-19—Preliminary Report</article-title>
<source/>New. Engl. J. Med.
          <year>2020</year>
<pub-id pub-id-type="doi">10.1056/NEJMoa2007764</pub-id>
</element-citation>
</ref>
<ref id="B5-nutrients-12-01718">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Russell</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Moss</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rigg</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Van Hemelrijck</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>COVID-19 and treatment with NSAIDs and corticosteroids: Should we be limiting their use in the clinical setting?</article-title>
<source/>Ecancermedicalscience
          <year>2020</year>
<volume>14</volume>
<pub-id pub-id-type="doi">10.3332/ecancer.2020.1023</pub-id>
</element-citation>
</ref>
<ref id="B6-nutrients-12-01718">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Funck-Brentano</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Salem</surname>
<given-names>J.-E.</given-names>
</name>
</person-group>
<article-title>Comment Chloroquine or hydroxychloroquine for COVID-19: Why might they be hazardous?</article-title>
<source/>Lancet
          <year>2020</year>
<pub-id pub-id-type="doi">10.1016/S0140-6736(20)31174-0</pub-id>
</element-citation>
</ref>
<ref id="B7-nutrients-12-01718">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mehra</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Desai</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Ruschitzka</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>A.N.</given-names>
</name>
</person-group>
<article-title>Articles Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: A multinational registry analysis</article-title>
<source/>Lancet
          <year>2020</year>
<pub-id pub-id-type="doi">10.1016/S0140-6736(20)31180-6</pub-id>
</element-citation>
</ref>
<ref id="B8-nutrients-12-01718">
<label>8.</label>
<element-citation publication-type="web">
<article-title>Coronavirus: WHO halts trials of hydroxychloroquine over safety fears—BBC News</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.bbc.com/news/health-52799120">https://www.bbc.com/news/health-52799120</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2020-05-28">(accessed on 28 May 2020)</date-in-citation>
</element-citation>
</ref>
<ref id="B9-nutrients-12-01718">
<label>9.</label>
<element-citation publication-type="gov">
<article-title>Tocilizumab in COVID-19 Pneumonia (TOCIVID-19)—Full Text View—ClinicalTrials.gov</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04317092">https://clinicaltrials.gov/ct2/show/NCT04317092</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2020-04-13">(accessed on 13 April 2020)</date-in-citation>
</element-citation>
</ref>
<ref id="B10-nutrients-12-01718">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holshue</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>DeBolt</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lindquist</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lofy</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Wiesman</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bruce</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Spitters</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ericson</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wilkerson</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tural</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>First Case of 2019 Novel Coronavirus in the United States</article-title>
<source/>New. Engl. J. Med.
          <year>2020</year>
<volume>382</volume>
<fpage>929</fpage>
<lpage>936</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa2001191</pub-id>
<pub-id pub-id-type="pmid">32004427</pub-id>
</element-citation>
</ref>
<ref id="B11-nutrients-12-01718">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffmann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kleine-Weber</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Schroeder</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Krüger</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Herrler</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Erichsen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schiergens</surname>
<given-names>T.S.</given-names>
</name>
<name>
<surname>Herrler</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>N.H.</given-names>
</name>
<name>
<surname>Nitsche</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor</article-title>
<source/>Cell
          <year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.cell.2020.02.052</pub-id>
</element-citation>
</ref>
<ref id="B12-nutrients-12-01718">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The digestive system is a potential route of 2019-nCov infection: A bioinformatics analysis based on single-cell transcriptomes</article-title>
<source/>bioRxiv
          <year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.01.30.927806</pub-id>
</element-citation>
</ref>
<ref id="B13-nutrients-12-01718">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bertram</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Heurich</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lavender</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gierer</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Danisch</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Perin</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lucas</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>P.S.</given-names>
</name>
<name>
<surname>Pöhlmann</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Soilleux</surname>
<given-names>E.J.</given-names>
</name>
</person-group>
<article-title>Influenza and SARS-Coronavirus Activating Proteases TMPRSS2 and HAT Are Expressed at Multiple Sites in Human Respiratory and Gastrointestinal Tracts</article-title>
<source/>PLoS ONE
          <year>2012</year>
<volume>7</volume>
<elocation-id>e35876</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0035876</pub-id>
<pub-id pub-id-type="pmid">22558251</pub-id>
</element-citation>
</ref>
<ref id="B14-nutrients-12-01718">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission</article-title>
<source/>Gastroenterology
          <year>2020</year>
<pub-id pub-id-type="doi">10.1053/j.gastro.2020.02.054</pub-id>
</element-citation>
</ref>
<ref id="B15-nutrients-12-01718">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>Z.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Evidence for gastrointestinal infection of SARS-CoV-2</article-title>
<source/>medRxiv
          <year>2020</year>
<pub-id pub-id-type="doi">10.1053/j.gastro.2020.02.055</pub-id>
<pub-id pub-id-type="pmid">32142773</pub-id>
</element-citation>
</ref>
<ref id="B16-nutrients-12-01718">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China</article-title>
<source/>JAMA J. Am. Med. Assoc.
          <year>2020</year>
<volume>323</volume>
<fpage>1061</fpage>
<lpage>1069</lpage>
<pub-id pub-id-type="doi">10.1001/jama.2020.1585</pub-id>
<pub-id pub-id-type="pmid">32031570</pub-id>
</element-citation>
</ref>
<ref id="B17-nutrients-12-01718">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leung</surname>
<given-names>W.K.</given-names>
</name>
<name>
<surname>To</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>P.K.S.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>H.L.Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>A.K.L.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yuen</surname>
<given-names>K.Y.</given-names>
</name>
<name>
<surname>Sung</surname>
<given-names>J.J.Y.</given-names>
</name>
</person-group>
<article-title>Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection</article-title>
<source/>Gastroenterology
          <year>2003</year>
<volume>125</volume>
<fpage>1011</fpage>
<lpage>1017</lpage>
<pub-id pub-id-type="doi">10.1016/j.gastro.2003.08.001</pub-id>
<pub-id pub-id-type="pmid">14517783</pub-id>
</element-citation>
</ref>
<ref id="B18-nutrients-12-01718">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hashimoto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Perlot</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Rehman</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Trichereau</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ishiguro</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Paolino</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sigl</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Hanada</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hanada</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lipinski</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammatio</article-title>
<source/>Nature
          <pub-id pub-id-type="doi">10.1038/nature11228</pub-id>
</element-citation>
</ref>
<ref id="B19-nutrients-12-01718">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lloyd-Price</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Abu-Ali</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Huttenhower</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>The healthy human microbiome</article-title>
<source/>Genome Med.
          <year>2016</year>
<volume>8</volume>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1186/s13073-016-0307-y</pub-id>
<pub-id pub-id-type="pmid">26750923</pub-id>
</element-citation>
</ref>
<ref id="B20-nutrients-12-01718">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huttenhower</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gevers</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Abubucker</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Badger</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Chinwalla</surname>
<given-names>A.T.</given-names>
</name>
<name>
<surname>Creasy</surname>
<given-names>H.H.</given-names>
</name>
<name>
<surname>Earl</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Fitzgerald</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Fulton</surname>
<given-names>R.S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Structure, function and diversity of the healthy human microbiome</article-title>
<source/>Nature
          <year>2012</year>
<volume>486</volume>
<fpage>207</fpage>
<lpage>214</lpage>
<pub-id pub-id-type="doi">10.1038/nature11234</pub-id>
<pub-id pub-id-type="pmid">22699609</pub-id>
</element-citation>
</ref>
<ref id="B21-nutrients-12-01718">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Methé</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Pop</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Creasy</surname>
<given-names>H.H.</given-names>
</name>
<name>
<surname>Giglio</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Huttenhower</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gevers</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Petrosino</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Abubucker</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Badger</surname>
<given-names>J.H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A framework for human microbiome research</article-title>
<source/>Nature
          <year>2012</year>
<volume>486</volume>
<fpage>215</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="doi">10.1038/nature11209</pub-id>
<pub-id pub-id-type="pmid">22699610</pub-id>
</element-citation>
</ref>
<ref id="B22-nutrients-12-01718">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hooper</surname>
<given-names>L.V.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>J.I.</given-names>
</name>
</person-group>
<article-title>Commensal host-bacterial relationships in the gut</article-title>
<source/>Science
          <year>2001</year>
<volume>292</volume>
<fpage>1115</fpage>
<lpage>1118</lpage>
<pub-id pub-id-type="doi">10.1126/science.1058709</pub-id>
<pub-id pub-id-type="pmid">11352068</pub-id>
</element-citation>
</ref>
<ref id="B23-nutrients-12-01718">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chervonsky</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Innate receptors and microbes in induction of autoimmunity</article-title>
<source/>Curr. Opin. Immunol.
          <year>2009</year>
<volume>21</volume>
<fpage>641</fpage>
<lpage>647</lpage>
<pub-id pub-id-type="doi">10.1016/j.coi.2009.08.003</pub-id>
<pub-id pub-id-type="pmid">19747810</pub-id>
</element-citation>
</ref>
<ref id="B24-nutrients-12-01718">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Round</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Mazmanian</surname>
<given-names>S.K.</given-names>
</name>
</person-group>
<article-title>The gut microbiota shapes intestinal immune responses during health and disease</article-title>
<source/>Nat. Rev. Immunol.
          <year>2009</year>
<volume>9</volume>
<fpage>313</fpage>
<lpage>323</lpage>
<pub-id pub-id-type="doi">10.1038/nri2515</pub-id>
<pub-id pub-id-type="pmid">19343057</pub-id>
</element-citation>
</ref>
<ref id="B25-nutrients-12-01718">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macpherson</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>N.L.</given-names>
</name>
</person-group>
<article-title>Interactions between commensal intestinal bacteria and the immune system</article-title>
<source/>Nat. Rev. Immunol.
          <year>2004</year>
<volume>4</volume>
<fpage>478</fpage>
<lpage>485</lpage>
<pub-id pub-id-type="doi">10.1038/nri1373</pub-id>
<pub-id pub-id-type="pmid">15173836</pub-id>
</element-citation>
</ref>
<ref id="B26-nutrients-12-01718">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Owaga</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hsieh</surname>
<given-names>R.H.</given-names>
</name>
<name>
<surname>Mugendi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Masuku</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shih</surname>
<given-names>C.K.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>J.S.</given-names>
</name>
</person-group>
<article-title>Th17 cells as potential probiotic therapeutic targets in inflammatory bowel diseases</article-title>
<source/>Int. J. Mol. Sci.
          <year>2015</year>
<volume>16</volume>
<fpage>20841</fpage>
<lpage>20858</lpage>
<pub-id pub-id-type="doi">10.3390/ijms160920841</pub-id>
<pub-id pub-id-type="pmid">26340622</pub-id>
</element-citation>
</ref>
<ref id="B27-nutrients-12-01718">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Francino</surname>
<given-names>M.P.</given-names>
</name>
</person-group>
<article-title>Early development of the gut microbiota and immune health</article-title>
<source/>Pathogens
          <year>2014</year>
<volume>3</volume>
<fpage>769</fpage>
<lpage>790</lpage>
<pub-id pub-id-type="doi">10.3390/pathogens3030769</pub-id>
<pub-id pub-id-type="pmid">25438024</pub-id>
</element-citation>
</ref>
<ref id="B28-nutrients-12-01718">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hussell</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>T.J.</given-names>
</name>
</person-group>
<article-title>Alveolar macrophages: Plasticity in a tissue-specific context</article-title>
<source/>Nat. Rev. Immunol.
          <year>2014</year>
<volume>14</volume>
<fpage>81</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.1038/nri3600</pub-id>
<pub-id pub-id-type="pmid">24445666</pub-id>
</element-citation>
</ref>
<ref id="B29-nutrients-12-01718">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soroosh</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Doherty</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>Y.F.</given-names>
</name>
<name>
<surname>Mikulski</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Khorram</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Rosenthal</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Broide</surname>
<given-names>D.H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lung-resident tissue macrophages generate Foxp3+ regulatory T cells and promote airway tolerance</article-title>
<source/>J. Exp. Med.
          <year>2013</year>
<volume>210</volume>
<fpage>775</fpage>
<lpage>788</lpage>
<pub-id pub-id-type="doi">10.1084/jem.20121849</pub-id>
<pub-id pub-id-type="pmid">23547101</pub-id>
</element-citation>
</ref>
<ref id="B30-nutrients-12-01718">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gollwitzer</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Saglani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Trompette</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yadava</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sherburn</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>McCoy</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Nicod</surname>
<given-names>L.P.</given-names>
</name>
<name>
<surname>Lloyd</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Marsland</surname>
<given-names>B.J.</given-names>
</name>
</person-group>
<article-title>Lung microbiota promotes tolerance to allergens in neonates via PD-L1</article-title>
<source/>Nat. Med.
          <year>2014</year>
<volume>20</volume>
<fpage>642</fpage>
<lpage>647</lpage>
<pub-id pub-id-type="doi">10.1038/nm.3568</pub-id>
<pub-id pub-id-type="pmid">24813249</pub-id>
</element-citation>
</ref>
<ref id="B31-nutrients-12-01718">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herbst</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sichelstiel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schär</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yadava</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bürki</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Cahenzli</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>McCoy</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Marsland</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>N.L.</given-names>
</name>
</person-group>
<article-title>Dysregulation of allergic airway inflammation in the absence of microbial colonization</article-title>
<source/>Am. J. Respir. Crit. Care Med.
          <year>2011</year>
<volume>184</volume>
<fpage>198</fpage>
<lpage>205</lpage>
<pub-id pub-id-type="doi">10.1164/rccm.201010-1574OC</pub-id>
<pub-id pub-id-type="pmid">21471101</pub-id>
</element-citation>
</ref>
<ref id="B32-nutrients-12-01718">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Larsen</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Musavian</surname>
<given-names>H.S.</given-names>
</name>
<name>
<surname>Butt</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Ingvorsen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Thysen</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Brix</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Chronic obstructive pulmonary disease and asthma-associated Proteobacteria, but not commensal Prevotella spp., promote Toll-like receptor 2-independent lung inflammation and pathology</article-title>
<source/>Immunology
          <year>2015</year>
<volume>144</volume>
<fpage>333</fpage>
<lpage>342</lpage>
<pub-id pub-id-type="doi">10.1111/imm.12376</pub-id>
<pub-id pub-id-type="pmid">25179236</pub-id>
</element-citation>
</ref>
<ref id="B33-nutrients-12-01718">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Segal</surname>
<given-names>L.N.</given-names>
</name>
<name>
<surname>Clemente</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Tsay</surname>
<given-names>J.C.J.</given-names>
</name>
<name>
<surname>Koralov</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>B.C.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>B.G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ghedin</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype</article-title>
<source/>Nat. Microbiol.
          <year>2016</year>
<volume>1</volume>
<pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.31</pub-id>
</element-citation>
</ref>
<ref id="B34-nutrients-12-01718">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clemente</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Ursell</surname>
<given-names>L.K.</given-names>
</name>
<name>
<surname>Parfrey</surname>
<given-names>L.W.</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>The impact of the gut microbiota on human health: An integrative view</article-title>
<source/>Cell
          <year>2012</year>
<volume>148</volume>
<fpage>1258</fpage>
<lpage>1270</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2012.01.035</pub-id>
<pub-id pub-id-type="pmid">22424233</pub-id>
</element-citation>
</ref>
<ref id="B35-nutrients-12-01718">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Degruttola</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Low</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mizoguchi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mizoguchi</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Current understanding of dysbiosis in disease in human and animal models</article-title>
<source/>Inflamm. Bowel Dis.
          <year>2016</year>
<volume>22</volume>
<fpage>1137</fpage>
<lpage>1150</lpage>
<pub-id pub-id-type="doi">10.1097/MIB.0000000000000750</pub-id>
<pub-id pub-id-type="pmid">27070911</pub-id>
</element-citation>
</ref>
<ref id="B36-nutrients-12-01718">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pothmann</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Illing</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wiegand</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hartmann</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Elsner</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>The Microbiome and Atopic Dermatitis: A Review</article-title>
<source/>Am. J. Clin. Dermatol.
          <year>2019</year>
<volume>20</volume>
<fpage>749</fpage>
<lpage>761</lpage>
<pub-id pub-id-type="doi">10.1007/s40257-019-00467-1</pub-id>
<pub-id pub-id-type="pmid">31444782</pub-id>
</element-citation>
</ref>
<ref id="B37-nutrients-12-01718">
<label>37.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Pulikkan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mazumder</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Grace</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Role of the Gut Microbiome in Autism Spectrum Disorders</article-title>
<source/>Advances in Experimental Medicine and Biology
          <publisher-name>Springer New York LLC</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>2019</year>
<volume>Volume 1118</volume>
<fpage>253</fpage>
<lpage>269</lpage>
</element-citation>
</ref>
<ref id="B38-nutrients-12-01718">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumpitsch</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Koskinen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Schöpf</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Moissl-Eichinger</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>The microbiome of the upper respiratory tract in health and disease</article-title>
<source/>BMC Biol.
          <year>2019</year>
<volume>17</volume>
<elocation-id>87</elocation-id>
<pub-id pub-id-type="doi">10.1186/s12915-019-0703-z</pub-id>
<pub-id pub-id-type="pmid">31699101</pub-id>
</element-citation>
</ref>
<ref id="B39-nutrients-12-01718">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.L.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Luan</surname>
<given-names>X.Q.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>T.T.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Dysbiosis of lower respiratory tract microbiome are associated with inflammation and microbial function variety</article-title>
<source/>Respir. Res.
          <year>2019</year>
<volume>20</volume>
<pub-id pub-id-type="doi">10.1186/s12931-019-1246-0</pub-id>
</element-citation>
</ref>
<ref id="B40-nutrients-12-01718">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dang</surname>
<given-names>A.T.</given-names>
</name>
<name>
<surname>Marsland</surname>
<given-names>B.J.</given-names>
</name>
</person-group>
<article-title>Microbes, metabolites, and the gut–lung axis</article-title>
<source/>Mucosal Immunol.
          <year>2019</year>
<volume>12</volume>
<fpage>843</fpage>
<lpage>850</lpage>
<pub-id pub-id-type="doi">10.1038/s41385-019-0160-6</pub-id>
<pub-id pub-id-type="pmid">30976087</pub-id>
</element-citation>
</ref>
<ref id="B41-nutrients-12-01718">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karst</surname>
<given-names>S.M.</given-names>
</name>
</person-group>
<article-title>The influence of commensal bacteria on infection with enteric viruses</article-title>
<source/>Nat. Rev. Microbiol.
          <year>2016</year>
<volume>14</volume>
<fpage>197</fpage>
<lpage>204</lpage>
<pub-id pub-id-type="doi">10.1038/nrmicro.2015.25</pub-id>
<pub-id pub-id-type="pmid">26853118</pub-id>
</element-citation>
</ref>
<ref id="B42-nutrients-12-01718">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berger</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Mainou</surname>
<given-names>B.A.</given-names>
</name>
</person-group>
<article-title>Interactions between enteric bacteria and eukaryotic viruses impact the outcome of infection</article-title>
<source/>Viruses
          <year>2018</year>
<volume>10</volume>
<elocation-id>19</elocation-id>
<pub-id pub-id-type="doi">10.3390/v10010019</pub-id>
</element-citation>
</ref>
<ref id="B43-nutrients-12-01718">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pfeiffer</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Virgin</surname>
<given-names>H.W.</given-names>
</name>
</person-group>
<article-title>Viral immunity. Transkingdom control of viral infection and immunity in the mammalian intestine</article-title>
<source/>Science
          <year>2016</year>
<volume>351</volume>
<pub-id pub-id-type="doi">10.1126/science.aad5872</pub-id>
</element-citation>
</ref>
<ref id="B44-nutrients-12-01718">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sullender</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Baldridge</surname>
<given-names>M.T.</given-names>
</name>
</person-group>
<article-title>Norovirus interactions with the commensal microbiota</article-title>
<source/>PLoS Pathog.
          <year>2018</year>
<volume>14</volume>
<elocation-id>e1007183</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1007183</pub-id>
<pub-id pub-id-type="pmid">30188944</pub-id>
</element-citation>
</ref>
<ref id="B45-nutrients-12-01718">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robinson</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Pfeiffer</surname>
<given-names>J.K.</given-names>
</name>
</person-group>
<article-title>Viruses and the Microbiota</article-title>
<source/>Annu. Rev. Virol.
          <year>2014</year>
<volume>1</volume>
<fpage>55</fpage>
<lpage>69</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-virology-031413-085550</pub-id>
<pub-id pub-id-type="pmid">25821837</pub-id>
</element-citation>
</ref>
<ref id="B46-nutrients-12-01718">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edouard</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Million</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bachar</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dubourg</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Michelle</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ninove</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Charrel</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Raoult</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>The nasopharyngeal microbiota in patients with viral respiratory tract infections is enriched in bacterial pathogens</article-title>
<source/>Eur. J. Clin. Microbiol. Infect. Dis.
          <year>2018</year>
<volume>37</volume>
<fpage>1725</fpage>
<lpage>1733</lpage>
<pub-id pub-id-type="doi">10.1007/s10096-018-3305-8</pub-id>
<pub-id pub-id-type="pmid">30033505</pub-id>
</element-citation>
</ref>
<ref id="B47-nutrients-12-01718">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>16S rDNA sequencing analysis of upper respiratory tract flora in patients with influenza H1N1 virus infection</article-title>
<source/>Front. Lab. Med.
          <year>2017</year>
<volume>1</volume>
<fpage>16</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="doi">10.1016/j.flm.2017.02.005</pub-id>
</element-citation>
</ref>
<ref id="B48-nutrients-12-01718">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Influence of novel highly pathogenic avian influenza A (H5N1) virus infection on migrating whooper swans fecal microbiota</article-title>
<source/>Front. Cell. Infect. Microbiol.
          <year>2018</year>
<volume>8</volume>
<pub-id pub-id-type="doi">10.3389/fcimb.2018.00046</pub-id>
</element-citation>
</ref>
<ref id="B49-nutrients-12-01718">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Groves</surname>
<given-names>H.T.</given-names>
</name>
<name>
<surname>Cuthbertson</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>James</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Moffatt</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Tregoning</surname>
<given-names>J.S.</given-names>
</name>
</person-group>
<article-title>Respiratory disease following viral lung infection alters the murine gut microbiota</article-title>
<source/>Front. Immunol.
          <year>2018</year>
<volume>9</volume>
<pub-id pub-id-type="doi">10.3389/fimmu.2018.00182</pub-id>
<pub-id pub-id-type="pmid">29483910</pub-id>
</element-citation>
</ref>
<ref id="B50-nutrients-12-01718">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yildiz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mazel-Sanchez</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kandasamy</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Manicassamy</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Schmolke</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosis</article-title>
<source/>Microbiome
          <year>2018</year>
<volume>6</volume>
<pub-id pub-id-type="doi">10.1186/s40168-017-0386-z</pub-id>
</element-citation>
</ref>
<ref id="B51-nutrients-12-01718">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lian</surname>
<given-names>Z.X.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Respiratory influenza virus infection induces intestinal immune injury via microbiotamediated Th17 cell-dependent inflammation</article-title>
<source/>J. Exp. Med.
          <year>2014</year>
<volume>211</volume>
<fpage>2397</fpage>
<lpage>2410</lpage>
<pub-id pub-id-type="doi">10.1084/jem.20140625</pub-id>
<pub-id pub-id-type="pmid">25366965</pub-id>
</element-citation>
</ref>
<ref id="B52-nutrients-12-01718">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>X.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prolonged presence of SARS-CoV-2 viral RNA in faecal samples</article-title>
<source/>Lancet Gastroenterol. Hepatol.
          <year>2020</year>
<volume>5</volume>
<fpage>434</fpage>
<lpage>435</lpage>
<pub-id pub-id-type="doi">10.1016/S2468-1253(20)30083-2</pub-id>
<pub-id pub-id-type="pmid">32199469</pub-id>
</element-citation>
</ref>
<ref id="B53-nutrients-12-01718">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marchesi</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Fava</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hermes</surname>
<given-names>G.D.A.</given-names>
</name>
<name>
<surname>Hirschfield</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Hold</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Quraishi</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Kinross</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Smidt</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tuohy</surname>
<given-names>K.M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The gut microbiota and host health: A new clinical frontier</article-title>
<source/>Gut
          <year>2016</year>
<volume>65</volume>
<fpage>330</fpage>
<lpage>339</lpage>
<pub-id pub-id-type="doi">10.1136/gutjnl-2015-309990</pub-id>
<pub-id pub-id-type="pmid">26338727</pub-id>
</element-citation>
</ref>
<ref id="B54-nutrients-12-01718">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anuradha</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rajeshwari</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Probiotics in Health and Disease</article-title>
<source/>J. Indian Acad. Clin. Med.
          <year>2005</year>
<volume>6</volume>
<fpage>67</fpage>
<lpage>72</lpage>
</element-citation>
</ref>
<ref id="B55-nutrients-12-01718">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leyer</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mubasher</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Reifer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ouwehand</surname>
<given-names>A.C.</given-names>
</name>
</person-group>
<article-title>Probiotic effects on cold and influenza-like symptom incidence and duration in children</article-title>
<source/>Pediatrics
          <year>2009</year>
<volume>124</volume>
<fpage>e172</fpage>
<lpage>e179</lpage>
<pub-id pub-id-type="doi">10.1542/peds.2008-2666</pub-id>
<pub-id pub-id-type="pmid">19651563</pub-id>
</element-citation>
</ref>
<ref id="B56-nutrients-12-01718">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rautava</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Salminen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Isolauri</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Specific probiotics in reducing the risk of acute infections in infancy—A randomised, double-blind, placebo-controlled study</article-title>
<source/>Br. J. Nutr.
          <year>2009</year>
<volume>101</volume>
<fpage>1722</fpage>
<lpage>1726</lpage>
<pub-id pub-id-type="doi">10.1017/S0007114508116282</pub-id>
<pub-id pub-id-type="pmid">18986600</pub-id>
</element-citation>
</ref>
<ref id="B57-nutrients-12-01718">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hatakka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Savilahti</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Pönkä</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Meurman</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Poussa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Näse</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Saxelin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Korpela</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Effect of long term consumption of probiotic milk on infections in children attending day care centres: Double blind, randomised trial</article-title>
<source/>Br. Med. J.
          <year>2001</year>
<volume>322</volume>
<fpage>1327</fpage>
<lpage>1329</lpage>
<pub-id pub-id-type="doi">10.1136/bmj.322.7298.1327</pub-id>
<pub-id pub-id-type="pmid">11387176</pub-id>
</element-citation>
</ref>
<ref id="B58-nutrients-12-01718">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanders</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Merenstein</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Reid</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>G.R.</given-names>
</name>
<name>
<surname>Rastall</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>Probiotics and prebiotics in intestinal health and disease: From biology to the clinic</article-title>
<source/>Nat. Rev. Gastroenterol. Hepatol.
          <year>2019</year>
<volume>16</volume>
<fpage>605</fpage>
<lpage>616</lpage>
<pub-id pub-id-type="doi">10.1038/s41575-019-0173-3</pub-id>
<pub-id pub-id-type="pmid">31296969</pub-id>
</element-citation>
</ref>
<ref id="B59-nutrients-12-01718">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanders</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Guarner</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Guerrant</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Holt</surname>
<given-names>P.R.</given-names>
</name>
<name>
<surname>Quigley</surname>
<given-names>E.M.M.</given-names>
</name>
<name>
<surname>Sartor</surname>
<given-names>R.B.</given-names>
</name>
<name>
<surname>Sherman</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Mayer</surname>
<given-names>E.A.</given-names>
</name>
</person-group>
<article-title>An update on the use and investigation of probiotics in health and disease</article-title>
<source/>Gut
          <year>2013</year>
<volume>62</volume>
<fpage>787</fpage>
<lpage>796</lpage>
<pub-id pub-id-type="doi">10.1136/gutjnl-2012-302504</pub-id>
<pub-id pub-id-type="pmid">23474420</pub-id>
</element-citation>
</ref>
<ref id="B60-nutrients-12-01718">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hao</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>B.R.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C.Q.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Probiotics for preventing acute upper respiratory tract infections</article-title>
<source/>Cochrane Database Syst. Rev.
          <year>2011</year>
<elocation-id>CD006895</elocation-id>
<pub-id pub-id-type="doi">10.1002/14651858.CD006895.pub2</pub-id>
<pub-id pub-id-type="pmid">21901706</pub-id>
</element-citation>
</ref>
<ref id="B61-nutrients-12-01718">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Botić</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Klingberg</surname>
<given-names>T.D.</given-names>
</name>
<name>
<surname>Weingartl</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cencič</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>A novel eukaryotic cell culture model to study antiviral activity of potential probiotic bacteria</article-title>
<source/>Int. J. Food Microbiol.
          <year>2007</year>
<volume>115</volume>
<fpage>227</fpage>
<lpage>234</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2006.10.044</pub-id>
<pub-id pub-id-type="pmid">17261339</pub-id>
</element-citation>
</ref>
<ref id="B62-nutrients-12-01718">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mastromarino</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cacciotti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Masci</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mosca</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Antiviral activity of Lactobacillus brevis towards herpes simplex virus type 2: Role of cell wall associated components</article-title>
<source/>Anaerobe
          <year>2011</year>
<volume>17</volume>
<fpage>334</fpage>
<lpage>336</lpage>
<pub-id pub-id-type="doi">10.1016/j.anaerobe.2011.04.022</pub-id>
<pub-id pub-id-type="pmid">21621625</pub-id>
</element-citation>
</ref>
<ref id="B63-nutrients-12-01718">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biliavska</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pankivska</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Povnitsa</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Zagorodnya</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Antiviral activity of exopolysaccharides produced by lactic acid bacteria of the genera Pediococcus, Leuconostoc and Lactobacillus against human adenovirus type 5</article-title>
<source/>Medicina
          <year>2019</year>
<volume>55</volume>
<elocation-id>519</elocation-id>
<pub-id pub-id-type="doi">10.3390/medicina55090519</pub-id>
</element-citation>
</ref>
<ref id="B64-nutrients-12-01718">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salva</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nuñez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Villena</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ramón</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Font</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Alvarez</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Development of a fermented goats’ milk containing Lactobacillus rhamnosus: In vivo study of health benefits</article-title>
<source/>J. Sci. Food Agric.
          <year>2011</year>
<volume>91</volume>
<fpage>2355</fpage>
<lpage>2362</lpage>
<pub-id pub-id-type="doi">10.1002/jsfa.4467</pub-id>
<pub-id pub-id-type="pmid">21604277</pub-id>
</element-citation>
</ref>
<ref id="B65-nutrients-12-01718">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiss</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Rasmussen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zeuthen</surname>
<given-names>L.H.</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>B.N.</given-names>
</name>
<name>
<surname>Jarmer</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jespersen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Frøkiær</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Lactobacillus acidophilus induces virus immune defence genes in murine dendritic cells by a Toll-like receptor-2-dependent mechanism</article-title>
<source/>Immunology
          <year>2010</year>
<volume>131</volume>
<fpage>268</fpage>
<lpage>281</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2567.2010.03301.x</pub-id>
<pub-id pub-id-type="pmid">20545783</pub-id>
</element-citation>
</ref>
<ref id="B66-nutrients-12-01718">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miettinen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lehtonen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Julkunen</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Matikainen</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Lactobacilli and Streptococci Activate NF-κB and STAT Signaling Pathways in Human Macrophages</article-title>
<source/>J. Immunol.
          <year>2000</year>
<volume>164</volume>
<fpage>3733</fpage>
<lpage>3740</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.164.7.3733</pub-id>
<pub-id pub-id-type="pmid">10725732</pub-id>
</element-citation>
</ref>
<ref id="B67-nutrients-12-01718">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiba</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Tomosada</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Vizoso-Pinto</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Salva</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tsukida</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kitazawa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Alvarez</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Villena</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Immunobiotic Lactobacillus rhamnosus improves resistance of infant mice against respiratory syncytial virus infection</article-title>
<source/>Int. Immunopharmacol.
          <year>2013</year>
<volume>17</volume>
<fpage>373</fpage>
<lpage>382</lpage>
<pub-id pub-id-type="doi">10.1016/j.intimp.2013.06.024</pub-id>
<pub-id pub-id-type="pmid">23838113</pub-id>
</element-citation>
</ref>
<ref id="B68-nutrients-12-01718">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waki</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yajima</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Suganuma</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Buddle</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Heiser</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Oral administration of Lactobacillus brevis KB290 to mice alleviates clinical symptoms following influenza virus infection</article-title>
<source/>Lett. Appl. Microbiol.
          <year>2014</year>
<volume>58</volume>
<fpage>87</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.1111/lam.12160</pub-id>
<pub-id pub-id-type="pmid">24329975</pub-id>
</element-citation>
</ref>
<ref id="B69-nutrients-12-01718">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bae</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.</given-names>
<suffix>II</suffix>
</name>
<name>
<surname>Park</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>I.H.</given-names>
</name>
<name>
<surname>Joo</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ryu</surname>
<given-names>B.H.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>M.S.</given-names>
</name>
</person-group>
<article-title>Effects of lactobacillus plantarum and leuconostoc mesenteroides probiotics on human seasonal and Avian Influenza Viruses</article-title>
<source/>J. Microbiol. Biotechnol.
          <year>2018</year>
<volume>28</volume>
<fpage>893</fpage>
<lpage>901</lpage>
<pub-id pub-id-type="doi">10.4014/jmb.1804.04001</pub-id>
<pub-id pub-id-type="pmid">29847863</pub-id>
</element-citation>
</ref>
<ref id="B70-nutrients-12-01718">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harata</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hiruta</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kawase</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kubota</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hiramatsu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yausi</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responses</article-title>
<source/>Lett. Appl. Microbiol.
          <year>2010</year>
<volume>50</volume>
<fpage>597</fpage>
<lpage>602</lpage>
<pub-id pub-id-type="doi">10.1111/j.1472-765X.2010.02844.x</pub-id>
<pub-id pub-id-type="pmid">20438620</pub-id>
</element-citation>
</ref>
<ref id="B71-nutrients-12-01718">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Belkacem</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Serafini</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wheeler</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Derrien</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Boucinha</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Couesnon</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cerf-Bensussan</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gomperts Boneca</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Di Santo</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Taha</surname>
<given-names>M.-K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lactobacillus paracasei feeding improves immune control of influenza infection in mice</article-title>
<source/>PLoS ONE
          <year>2017</year>
<volume>12</volume>
<elocation-id>e0184976</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0184976</pub-id>
<pub-id pub-id-type="pmid">28931041</pub-id>
</element-citation>
</ref>
<ref id="B72-nutrients-12-01718">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahooti</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Abdolalipour</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Salehzadeh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mohebbi</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Gorji</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ghaemi</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Immunomodulatory and prophylactic effects of Bifidobacterium bifidum probiotic strain on influenza infection in mice</article-title>
<source/>World J. Microbiol. Biotechnol.
          <year>2019</year>
<volume>35</volume>
<fpage>91</fpage>
<pub-id pub-id-type="doi">10.1007/s11274-019-2667-0</pub-id>
<pub-id pub-id-type="pmid">31161259</pub-id>
</element-citation>
</ref>
<ref id="B73-nutrients-12-01718">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corridoni</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pastorelli</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mattioli</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Locovei</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ishikawa</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Arseneau</surname>
<given-names>K.O.</given-names>
</name>
<name>
<surname>Chieppa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cominelli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Pizarro</surname>
<given-names>T.T.</given-names>
</name>
</person-group>
<article-title>Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism</article-title>
<source/>PLoS ONE
          <year>2012</year>
<volume>7</volume>
<elocation-id>e42067</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0042067</pub-id>
<pub-id pub-id-type="pmid">22848704</pub-id>
</element-citation>
</ref>
<ref id="B74-nutrients-12-01718">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pagnini</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Saeed</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bamias</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Arseneau</surname>
<given-names>K.O.</given-names>
</name>
<name>
<surname>Pizarro</surname>
<given-names>T.T.</given-names>
</name>
<name>
<surname>Cominelli</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Probiotics promote gut health through stimulation of epithelial innate immunity</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2010</year>
<volume>107</volume>
<fpage>454</fpage>
<lpage>459</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0910307107</pub-id>
<pub-id pub-id-type="pmid">20018654</pub-id>
</element-citation>
</ref>
<ref id="B75-nutrients-12-01718">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sindhu</surname>
<given-names>K.N.C.</given-names>
</name>
<name>
<surname>Sowmyanarayanan</surname>
<given-names>T.V.</given-names>
</name>
<name>
<surname>Paul</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Babji</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ajjampur</surname>
<given-names>S.S.R.</given-names>
</name>
<name>
<surname>Priyadarshini</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sarkar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Balasubramanian</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Wanke</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>H.D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus rhamnosus GG: A randomized, double-blind, placebo-controlled trial</article-title>
<source/>Clin. Infect. Dis.
          <year>2014</year>
<volume>58</volume>
<fpage>1107</fpage>
<lpage>1115</lpage>
<pub-id pub-id-type="doi">10.1093/cid/ciu065</pub-id>
<pub-id pub-id-type="pmid">24501384</pub-id>
</element-citation>
</ref>
<ref id="B76-nutrients-12-01718">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khailova</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Baird</surname>
<given-names>C.H.</given-names>
</name>
<name>
<surname>Rush</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wischmeyer</surname>
<given-names>P.E.</given-names>
</name>
</person-group>
<article-title>Lactobacillus rhamnosus GG treatment improves intestinal permeability and modulates inflammatory response and homeostasis of spleen and colon in experimental model of Pseudomonas aeruginosa pneumonia</article-title>
<source/>Clin. Nutr.
          <year>2017</year>
<volume>36</volume>
<fpage>1549</fpage>
<lpage>1557</lpage>
<pub-id pub-id-type="doi">10.1016/j.clnu.2016.09.025</pub-id>
<pub-id pub-id-type="pmid">27745813</pub-id>
</element-citation>
</ref>
<ref id="B77-nutrients-12-01718">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eguchi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fujitani</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nakagawa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Miyazaki</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Prevention of respiratory syncytial virus infection with probiotic lactic acid bacterium Lactobacillus gasseri SBT2055</article-title>
<source/>Sci. Rep.
          <year>2019</year>
<volume>9</volume>
<pub-id pub-id-type="doi">10.1038/s41598-019-39602-7</pub-id>
<pub-id pub-id-type="pmid">30886158</pub-id>
</element-citation>
</ref>
<ref id="B78-nutrients-12-01718">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Percopo</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brenner</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Krumholz</surname>
<given-names>J.O.</given-names>
</name>
<name>
<surname>Break</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Laky</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Rosenberg</surname>
<given-names>H.F.</given-names>
</name>
</person-group>
<article-title>Critical Adverse Impact of IL-6 in Acute Pneumovirus Infection</article-title>
<source/>J. Immunol.
          <year>2019</year>
<volume>202</volume>
<fpage>871</fpage>
<lpage>882</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.1800927</pub-id>
<pub-id pub-id-type="pmid">30578308</pub-id>
</element-citation>
</ref>
<ref id="B79-nutrients-12-01718">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turner</surname>
<given-names>R.B.</given-names>
</name>
<name>
<surname>Woodfolk</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Borish</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Steinke</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Patrie</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Muehling</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Lahtinen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lehtinen</surname>
<given-names>M.J.</given-names>
</name>
</person-group>
<article-title>Effect of probiotic on innate inflammatory response and viral shedding in experimental rhinovirus infection—A randomised controlled trial</article-title>
<source/>Benef. Microbes
          <year>2017</year>
<volume>8</volume>
<fpage>207</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="doi">10.3920/BM2016.0160</pub-id>
<pub-id pub-id-type="pmid">28343401</pub-id>
</element-citation>
</ref>
<ref id="B80-nutrients-12-01718">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>X.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</article-title>
<source/>Lancet
          <year>2020</year>
<volume>395</volume>
<fpage>497</fpage>
<lpage>506</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(20)30183-5</pub-id>
<pub-id pub-id-type="pmid">31986264</pub-id>
</element-citation>
</ref>
<ref id="B81-nutrients-12-01718">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peiris</surname>
<given-names>J.S.M.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>V.C.C.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>K.S.</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>I.F.N.</given-names>
</name>
<name>
<surname>Poon</surname>
<given-names>L.L.M.</given-names>
</name>
<name>
<surname>Law</surname>
<given-names>K.I.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>B.S.F.</given-names>
</name>
<name>
<surname>Hon</surname>
<given-names>T.Y.W.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>C.S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study</article-title>
<source/>Lancet
          <year>2003</year>
<volume>361</volume>
<fpage>1767</fpage>
<lpage>1772</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(03)13412-5</pub-id>
<pub-id pub-id-type="pmid">12781535</pub-id>
</element-citation>
</ref>
<ref id="B82-nutrients-12-01718">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prompetchara</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ketloy</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Palaga</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic</article-title>
<source/>Asian Pac. J. Allergy Immunol.
          <year>2020</year>
<volume>38</volume>
<fpage>1</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">32105090</pub-id>
</element-citation>
</ref>
<ref id="B83-nutrients-12-01718">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>S.Y.</given-names>
</name>
</person-group>
<article-title>Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer</article-title>
<source/>J. Thorac. Oncol.
          <year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.jtho.2020.02.010</pub-id>
</element-citation>
</ref>
<ref id="B84-nutrients-12-01718">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pathological findings of COVID-19 associated with acute respiratory distress syndrome</article-title>
<source/>Lancet Respir. Med.
          <year>2020</year>
<volume>8</volume>
<fpage>420</fpage>
<lpage>422</lpage>
<pub-id pub-id-type="doi">10.1016/S2213-2600(20)30076-X</pub-id>
<pub-id pub-id-type="pmid">32085846</pub-id>
</element-citation>
</ref>
<ref id="B85-nutrients-12-01718">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>Q.Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.X.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>J.Y.</given-names>
</name>
</person-group>
<article-title>2019 Novel coronavirus infection and gastrointestinal tract</article-title>
<source/>J. Dig. Dis.
          <year>2020</year>
<volume>21</volume>
<fpage>125</fpage>
<lpage>126</lpage>
<pub-id pub-id-type="doi">10.1111/1751-2980.12851</pub-id>
<pub-id pub-id-type="pmid">32096611</pub-id>
</element-citation>
</ref>
<ref id="B86-nutrients-12-01718">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ni</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Management of COVID-19: The Zhejiang experience</article-title>
<source/>Zhejiang Da Xue Xue Bao. Yi Xue Ban
          <year>2020</year>
<volume>49</volume>
<fpage>147</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="pmid">32391658</pub-id>
</element-citation>
</ref>
<ref id="B87-nutrients-12-01718">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mak</surname>
<given-names>J.W.Y.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>F.K.L.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>S.C.</given-names>
</name>
</person-group>
<article-title>Probiotics and COVID-19: One size does not fit all</article-title>
<source/>Lancet Gastroenterol. Hepatol.
          <year>2020</year>
<pub-id pub-id-type="doi">10.1016/S2468-1253(20)30122-9</pub-id>
</element-citation>
</ref>
<ref id="B88-nutrients-12-01718">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Huange</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Alterations of the Gut Microbiota in Patients with COVID-19 or H1N1 Influenza</article-title>
<source/>Clin. Infect. Dis.
          <year>2020</year>
<elocation-id>ciaa709</elocation-id>
<pub-id pub-id-type="doi">10.1093/cid/ciaa709</pub-id>
<pub-id pub-id-type="pmid">32497191</pub-id>
</element-citation>
</ref>
<ref id="B89-nutrients-12-01718">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Didari</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Solki</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mozaffari</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nikfar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Abdollahi</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>A systematic review of the safety of probiotics</article-title>
<source/>Expert Opin. Drug Saf.
          <year>2014</year>
<volume>13</volume>
<fpage>227</fpage>
<lpage>239</lpage>
<pub-id pub-id-type="doi">10.1517/14740338.2014.872627</pub-id>
<pub-id pub-id-type="pmid">24405164</pub-id>
</element-citation>
</ref>
<ref id="B90-nutrients-12-01718">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dhar</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mohanty</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Gut microbiota and Covid-19- possible link and implications</article-title>
<source/>Virus Res.
          <year>2020</year>
<volume>285</volume>
<elocation-id>198018</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.virusres.2020.198018</pub-id>
<pub-id pub-id-type="pmid">32430279</pub-id>
</element-citation>
</ref>
<ref id="B91-nutrients-12-01718">
<label>91.</label>
<element-citation publication-type="gov">
<person-group person-group-type="author">
<collab>Biosearch S.A.</collab>
</person-group>
<article-title>Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04366180?cond=NCT04366180&amp;draw=2&amp;rank=1">https://clinicaltrials.gov/ct2/show/NCT04366180?cond=NCT04366180&amp;draw=2&amp;rank=1</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2020-06-05">(accessed on 5 June 2020)</date-in-citation>
</element-citation>
</ref>
<ref id="B92-nutrients-12-01718">
<label>92.</label>
<element-citation publication-type="gov">
<person-group person-group-type="author">
<collab>University of Roma La Sapienza</collab>
</person-group>
<article-title>Bacteriotherapy in the Treatment of COVID-19</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04368351?term=lactobacillus&amp;cond=COVID&amp;draw=2">https://clinicaltrials.gov/ct2/show/NCT04368351?term=lactobacillus&amp;cond=COVID&amp;draw=2</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2020-06-05">(accessed on 5 June 2020)</date-in-citation>
</element-citation>
</ref>
<ref id="B93-nutrients-12-01718">
<label>93.</label>
<element-citation publication-type="gov">
<person-group person-group-type="author">
<name>
<surname>Poscia</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora (PROBIOZOVID)</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04366089?term=lactobacillus&amp;cond=COVID&amp;draw=2">https://clinicaltrials.gov/ct2/show/NCT04366089?term=lactobacillus&amp;cond=COVID&amp;draw=2</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2020-06-05">(accessed on 5 June 2020)</date-in-citation>
</element-citation>
</ref>
<ref id="B94-nutrients-12-01718">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loffredo</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Perri</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Catasca</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Pignatelli</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Brancorsini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nocella</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>De Falco</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bartimoccia</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Frati</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Carnevale</surname>
<given-names>R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dark chocolate acutely improves walking autonomy in patients with peripheral artery disease</article-title>
<source/>J. Am. Heart Assoc.
          <year>2014</year>
<volume>3</volume>
<pub-id pub-id-type="doi">10.1161/JAHA.114.001072</pub-id>
</element-citation>
</ref>
<ref id="B95-nutrients-12-01718">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cangemi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pignatelli</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Carnevale</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bartimoccia</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nocella</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Falcone</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Taliani</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Violi</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>SIXTUS Study Group Low-grade endotoxemia, gut permeability and platelet activation in community-acquired pneumonia</article-title>
<source/>J. Infect.
          <year>2016</year>
<volume>73</volume>
<fpage>107</fpage>
<lpage>114</lpage>
<pub-id pub-id-type="doi">10.1016/j.jinf.2016.05.013</pub-id>
<pub-id pub-id-type="pmid">27288596</pub-id>
</element-citation>
</ref>
<ref id="B96-nutrients-12-01718">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loffredo</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cangemi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Perri</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Catasca</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Calvieri</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Carnevale</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nocella</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Equitani</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ferro</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Violi</surname>
<given-names>F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impaired flow-mediated dilation in hospitalized patients with community-acquired pneumonia</article-title>
<source/>Eur. J. Intern. Med.
          <year>2016</year>
<volume>36</volume>
<fpage>74</fpage>
<lpage>80</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejim.2016.09.008</pub-id>
<pub-id pub-id-type="pmid">27727076</pub-id>
</element-citation>
</ref>
<ref id="B97-nutrients-12-01718">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruan</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China</article-title>
<source/>Intensive Care Med.
          <year>2020</year>
<volume>46</volume>
<fpage>846</fpage>
<lpage>848</lpage>
<pub-id pub-id-type="doi">10.1007/s00134-020-05991-x</pub-id>
<pub-id pub-id-type="pmid">32125452</pub-id>
</element-citation>
</ref>
<ref id="B98-nutrients-12-01718">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guzik</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Mohiddin</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Dimarco</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Savvatis</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Marelli-Berg</surname>
<given-names>F.M.</given-names>
</name>
<name>
<surname>Madhur</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Tomaszewski</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Maffia</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nicklin</surname>
<given-names>S.A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>COVID-19 and the cardiovascular system: Implications for risk assessment, diagnosis, and treatment options</article-title>
<source/>Cardiovasc. Res
          <year>2020</year>
<elocation-id>cvaa106</elocation-id>
<pub-id pub-id-type="doi">10.1093/cvr/cvaa106</pub-id>
<pub-id pub-id-type="pmid">32352535</pub-id>
</element-citation>
</ref>
<ref id="B99-nutrients-12-01718">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Violi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Basili</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nigro</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pignatelli</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Role of NADPH oxidase in atherosclerosis</article-title>
<source/>Future Cardiol.
          <year>2009</year>
<volume>5</volume>
<fpage>83</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.2217/14796678.5.1.83</pub-id>
<pub-id pub-id-type="pmid">19371206</pub-id>
</element-citation>
</ref>
<ref id="B100-nutrients-12-01718">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bayard</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Chamorro</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Motta</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hollenberg</surname>
<given-names>N.K.</given-names>
</name>
</person-group>
<article-title>Does flavanol intake influence mortality from nitric oxide-dependent processes? Ischemic heart disease, stroke, diabetes mellitus, and cancer in Panama</article-title>
<source/>Int. J. Med. Sci.
          <year>2007</year>
<volume>4</volume>
<fpage>53</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="doi">10.7150/ijms.4.53</pub-id>
<pub-id pub-id-type="pmid">17299579</pub-id>
</element-citation>
</ref>
<ref id="B101-nutrients-12-01718">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Babu</surname>
<given-names>P.V.A.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Green tea catechins and cardiovascular health: An update</article-title>
<source/>Curr. Med. Chem.
          <year>2008</year>
<volume>15</volume>
<fpage>1840</fpage>
<lpage>1850</lpage>
<pub-id pub-id-type="doi">10.2174/092986708785132979</pub-id>
<pub-id pub-id-type="pmid">18691042</pub-id>
</element-citation>
</ref>
<ref id="B102-nutrients-12-01718">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Ku</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>J.S.</given-names>
</name>
</person-group>
<article-title>Anticoagulant activities of curcumin and its derivative</article-title>
<source/>BMB Rep.
          <year>2012</year>
<volume>45</volume>
<fpage>221</fpage>
<lpage>226</lpage>
<pub-id pub-id-type="doi">10.5483/BMBRep.2012.45.4.221</pub-id>
<pub-id pub-id-type="pmid">22531131</pub-id>
</element-citation>
</ref>
<ref id="B103-nutrients-12-01718">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freedman</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Perlman</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Frei</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ivanov</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Deak</surname>
<given-names>L.R.</given-names>
</name>
<name>
<surname>Iafrati</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Folts</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release</article-title>
<source/>Circulation
          <year>2001</year>
<volume>103</volume>
<fpage>2792</fpage>
<lpage>2798</lpage>
<pub-id pub-id-type="doi">10.1161/01.CIR.103.23.2792</pub-id>
<pub-id pub-id-type="pmid">11401934</pub-id>
</element-citation>
</ref>
<ref id="B104-nutrients-12-01718">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yahfoufi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Alsadi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Jambi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Matar</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>The Immunomodulatory and Anti-Inflammatory Role of Polyphenols</article-title>
<source/>Nutrients
          <year>2018</year>
<volume>10</volume>
<elocation-id>1618</elocation-id>
<pub-id pub-id-type="doi">10.3390/nu10111618</pub-id>
<pub-id pub-id-type="pmid">30400131</pub-id>
</element-citation>
</ref>
<ref id="B105-nutrients-12-01718">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vázquez-Calvo</surname>
<given-names>Á.</given-names>
</name>
<name>
<surname>Jiménez de Oya</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Martín-Acebes</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Garcia-Moruno</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Saiz</surname>
<given-names>J.-C.</given-names>
</name>
</person-group>
<article-title>Antiviral Properties of the Natural Polyphenols Delphinidin and Epigallocatechin Gallate against the Flaviviruses West Nile Virus, Zika Virus, and Dengue Virus</article-title>
<source/>Front. Microbiol.
          <year>2017</year>
<volume>8</volume>
<fpage>1314</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2017.01314</pub-id>
<pub-id pub-id-type="pmid">28744282</pub-id>
</element-citation>
</ref>
<ref id="B106-nutrients-12-01718">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Utomo</surname>
<given-names>R.Y.</given-names>
</name>
<name>
<surname>Ikawati</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Meiyanto</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Revealing the Potency of Citrus and Galangal Constituents to Halt SARS-CoV-2 Infection</article-title>
<source/>Preprints.Org
          <year>2020</year>
<volume>2</volume>
<fpage>1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.20944/preprints202003.0214.v1</pub-id>
</element-citation>
</ref>
<ref id="B107-nutrients-12-01718">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hood</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>A Novel Combination of Vitamin C, Curcumin and Glycyrrhizic Acid Potentially Regulates Immune and Inflammatory Response Associated with Coronavirus Infections: A Perspective from System Biology Analysis</article-title>
<source/>Nutrients
          <year>2020</year>
<volume>12</volume>
<elocation-id>1193</elocation-id>
<pub-id pub-id-type="doi">10.3390/nu12041193</pub-id>
</element-citation>
</ref>
<ref id="B108-nutrients-12-01718">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Runfeng</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yunlong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jicheng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Weiqi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Qinhai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yongxia</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chufang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhenhua</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Haiming</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)</article-title>
<source/>Pharmacol. Res.
          <year>2020</year>
<volume>156</volume>
<fpage>104761</fpage>
<pub-id pub-id-type="doi">10.1016/j.phrs.2020.104761</pub-id>
<pub-id pub-id-type="pmid">32205232</pub-id>
</element-citation>
</ref>
<ref id="B109-nutrients-12-01718">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feldmann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Maini</surname>
<given-names>R.N.</given-names>
</name>
<name>
<surname>Woody</surname>
<given-names>J.N.</given-names>
</name>
<name>
<surname>Holgate</surname>
<given-names>S.T.</given-names>
</name>
<name>
<surname>Winter</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Rowland</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hussell</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed</article-title>
<source/>Lancet
          <year>2020</year>
<volume>395</volume>
<fpage>1407</fpage>
<lpage>1409</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(20)30858-8</pub-id>
<pub-id pub-id-type="pmid">32278362</pub-id>
</element-citation>
</ref>
<ref id="B110-nutrients-12-01718">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up</article-title>
<source/>J. Infect.
          <year>2020</year>
<volume>80</volume>
<pub-id pub-id-type="doi">10.1016/j.jinf.2020.03.019</pub-id>
<pub-id pub-id-type="pmid">32240670</pub-id>
</element-citation>
</ref>
<ref id="B111-nutrients-12-01718">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Charles</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Elliott</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Potter</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kalden</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Antoni</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Breedveld</surname>
<given-names>F.C.</given-names>
</name>
<name>
<surname>Smolen</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Eberl</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>de Woody</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Regulation of Cytokines, Cytokine Inhibitors, and Acute-Phase Proteins Following Anti-TNF-α Therapy in Rheumatoid Arthritis</article-title>
<source/>J. Immunol.
          <year>1999</year>
<volume>163</volume>
<fpage>1521</fpage>
<lpage>1528</lpage>
<pub-id pub-id-type="pmid">10415055</pub-id>
</element-citation>
</ref>
<ref id="B112-nutrients-12-01718">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paleolog</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Stark</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>McCloskey</surname>
<given-names>R.V.</given-names>
</name>
<name>
<surname>Feldmann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Maini</surname>
<given-names>R.N.</given-names>
</name>
</person-group>
<article-title>Modulation of Angiogenic Vascular Endothelial Growth Factor by Tumor Necrosis Factor Alpha and interleukin-1 in Rheumatoid Arthritis</article-title>
<source/>Arthritis Rheum.
          <year>1998</year>
<volume>41</volume>
<pub-id pub-id-type="doi">10.1002/1529-0131(199807)41:7&lt;1258::AID-ART17&gt;3.0.CO;2-1</pub-id>
</element-citation>
</ref>
<ref id="B113-nutrients-12-01718">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hussell</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Pennycook</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Openshaw</surname>
<given-names>P.J.M.</given-names>
</name>
</person-group>
<article-title>Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology</article-title>
<source/>Eur. J. Immunol.
          <year>2001</year>
<volume>31</volume>
<fpage>2566</fpage>
<lpage>2573</lpage>
<pub-id pub-id-type="doi">10.1002/1521-4141(200109)31:9&lt;2566::AID-IMMU2566&gt;3.0.CO;2-L</pub-id>
<pub-id pub-id-type="pmid">11536154</pub-id>
</element-citation>
</ref>
<ref id="B114-nutrients-12-01718">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jamilloux</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Henry</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Belot</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Viel</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fauter</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>El Jammal</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Walzer</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>François</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sève</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions</article-title>
<source/>Autoimmun. Rev.
          <year>2020</year>
<elocation-id>102567</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.autrev.2020.102567</pub-id>
<pub-id pub-id-type="pmid">32376392</pub-id>
</element-citation>
</ref>
<ref id="B115-nutrients-12-01718">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>May</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>F.E.</given-names>
</name>
</person-group>
<article-title>Role of vitamin C in the function of the vascular endothelium</article-title>
<source/>Antioxid. Redox Signal.
          <year>2013</year>
<volume>19</volume>
<fpage>2068</fpage>
<lpage>2083</lpage>
<pub-id pub-id-type="doi">10.1089/ars.2013.5205</pub-id>
<pub-id pub-id-type="pmid">23581713</pub-id>
</element-citation>
</ref>
<ref id="B116-nutrients-12-01718">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carr</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Maggini</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Vitamin C and immune function</article-title>
<source/>Nutrients
          <year>2017</year>
<volume>9</volume>
<elocation-id>1211</elocation-id>
<pub-id pub-id-type="doi">10.3390/nu9111211</pub-id>
</element-citation>
</ref>
<ref id="B117-nutrients-12-01718">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atherton</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Kratzing</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>The effect of ascorbic acid on infection of chick-embryo ciliated tracheal organ cultures by coronavirus</article-title>
<source/>Arch. Virol.
          <year>1978</year>
<volume>56</volume>
<fpage>195</fpage>
<lpage>199</lpage>
<pub-id pub-id-type="doi">10.1007/BF01317848</pub-id>
<pub-id pub-id-type="pmid">205194</pub-id>
</element-citation>
</ref>
<ref id="B118-nutrients-12-01718">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaik-Dasthagirisaheb</surname>
<given-names>Y.B.</given-names>
</name>
<name>
<surname>Varvara</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Murmura</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Saggini</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Caraffa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Antinolfi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tetè</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tripodi</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Conti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cianchetti</surname>
<given-names>E.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Role of vitamins D, e and C in immunity and inflammation</article-title>
<source/>J. Biol. Regul. Homeost. Agents
          <year>2013</year>
<volume>27</volume>
<fpage>291</fpage>
<lpage>295</lpage>
<pub-id pub-id-type="pmid">23830380</pub-id>
</element-citation>
</ref>
<ref id="B119-nutrients-12-01718">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gombart</surname>
<given-names>A.F.</given-names>
</name>
<name>
<surname>Pierre</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Maggini</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>A review of micronutrients and the immune system–working in harmony to reduce the risk of infection</article-title>
<source/>Nutrients
          <year>2020</year>
<volume>12</volume>
<elocation-id>236</elocation-id>
<pub-id pub-id-type="doi">10.3390/nu12010236</pub-id>
</element-citation>
</ref>
<ref id="B120-nutrients-12-01718">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>HESS</surname>
<given-names>A.F.</given-names>
</name>
</person-group>
<article-title>Diet, Nutrition and Infection</article-title>
<source/>New Engl. J. Med.
          <year>1932</year>
<volume>207</volume>
<fpage>637</fpage>
<lpage>648</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM193210132071501</pub-id>
</element-citation>
</ref>
<ref id="B121-nutrients-12-01718">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robertson</surname>
<given-names>E.C.</given-names>
</name>
</person-group>
<article-title>The Vitamins and Resistance to Infection</article-title>
<source/>Medicine
          <year>1934</year>
<volume>13</volume>
<fpage>123</fpage>
<lpage>206</lpage>
<pub-id pub-id-type="doi">10.1097/00005792-193405000-00001</pub-id>
</element-citation>
</ref>
<ref id="B122-nutrients-12-01718">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wintergerst</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Maggini</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hornig</surname>
<given-names>D.H.</given-names>
</name>
</person-group>
<article-title>Immune-enhancing role of Vitamin C and zinc and effect on clinical conditions</article-title>
<source/>Ann. Nutr. Metab.
          <year>2006</year>
<volume>50</volume>
<fpage>85</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="doi">10.1159/000090495</pub-id>
<pub-id pub-id-type="pmid">16373990</pub-id>
</element-citation>
</ref>
<ref id="B123-nutrients-12-01718">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spoelstra-De Man</surname>
<given-names>A.M.E.</given-names>
</name>
<name>
<surname>Elbers</surname>
<given-names>P.W.G.</given-names>
</name>
<name>
<surname>Oudemans-Van Straaten</surname>
<given-names>H.M.</given-names>
</name>
</person-group>
<article-title>Vitamin C: Should we supplement?</article-title>
<source/>Curr. Opin. Crit. Care
          <year>2018</year>
<volume>24</volume>
<fpage>248</fpage>
<lpage>255</lpage>
<pub-id pub-id-type="doi">10.1097/MCC.0000000000000510</pub-id>
<pub-id pub-id-type="pmid">29864039</pub-id>
</element-citation>
</ref>
<ref id="B124-nutrients-12-01718">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>T.K.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>H.R.</given-names>
</name>
<name>
<surname>Byun</surname>
<given-names>J.S.</given-names>
</name>
</person-group>
<article-title>Vitamin C supplementation reduces the odds of developing a common cold in Republic of Korea Army recruits: Randomised controlled trial</article-title>
<source/>BMJ Mil. Heal.
          <year>2020</year>
<pub-id pub-id-type="doi">10.1136/bmjmilitary-2019-001384</pub-id>
</element-citation>
</ref>
<ref id="B125-nutrients-12-01718">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hemilä</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Vitamin C and Infections</article-title>
<source/>Nutrients
          <year>2017</year>
<volume>9</volume>
<elocation-id>339</elocation-id>
<pub-id pub-id-type="doi">10.3390/nu9040339</pub-id>
</element-citation>
</ref>
<ref id="B126-nutrients-12-01718">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fisher</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Seropian</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Kraskauskas</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Thakkar</surname>
<given-names>J.N.</given-names>
</name>
<name>
<surname>Voelkel</surname>
<given-names>N.F.</given-names>
</name>
<name>
<surname>Fowler</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Natarajan</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Ascorbic acid attenuates lipopolysaccharide-induced acute lung injury</article-title>
<source/>Crit. Care Med.
          <year>2011</year>
<volume>39</volume>
<fpage>1454</fpage>
<lpage>1460</lpage>
<pub-id pub-id-type="doi">10.1097/CCM.0b013e3182120cb8</pub-id>
<pub-id pub-id-type="pmid">21358394</pub-id>
</element-citation>
</ref>
<ref id="B127-nutrients-12-01718">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fisher</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Kraskauskas</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Farkas</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wegelin</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Brophy</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Voelkel</surname>
<given-names>N.F.</given-names>
</name>
<name>
<surname>Fowler</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Natarajan</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Mechanisms of attenuation of abdominal sepsis induced acute lung injury by ascorbic acid</article-title>
<source/>Am. J. Physiol. Lung Cell. Mol. Physiol.
          <year>2012</year>
<volume>303</volume>
<fpage>L20</fpage>
<lpage>L32</lpage>
<pub-id pub-id-type="doi">10.1152/ajplung.00300.2011</pub-id>
<pub-id pub-id-type="pmid">22523283</pub-id>
</element-citation>
</ref>
<ref id="B128-nutrients-12-01718">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carr</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Rosengrave</surname>
<given-names>P.C.</given-names>
</name>
<name>
<surname>Bayer</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chambers</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mehrtens</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>G.M.</given-names>
</name>
</person-group>
<article-title>Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes</article-title>
<source/>Crit. Care
          <year>2017</year>
<volume>21</volume>
<fpage>300</fpage>
<pub-id pub-id-type="doi">10.1186/s13054-017-1891-y</pub-id>
<pub-id pub-id-type="pmid">29228951</pub-id>
</element-citation>
</ref>
<ref id="B129-nutrients-12-01718">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hemilä</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Louhiala</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Vitamin C for preventing and treating pneumonia</article-title>
<source/>Cochrane Database Syst. Rev.
          <year>2007</year>
<elocation-id>CD005532</elocation-id>
<pub-id pub-id-type="pmid">17253561</pub-id>
</element-citation>
</ref>
<ref id="B130-nutrients-12-01718">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marik</surname>
<given-names>P.E.</given-names>
</name>
<name>
<surname>Khangoora</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Rivera</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hooper</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Catravas</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study</article-title>
<source/>Chest
          <year>2017</year>
<volume>151</volume>
<fpage>1229</fpage>
<lpage>1238</lpage>
<pub-id pub-id-type="doi">10.1016/j.chest.2016.11.036</pub-id>
<pub-id pub-id-type="pmid">27940189</pub-id>
</element-citation>
</ref>
<ref id="B131-nutrients-12-01718">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>W.Y.</given-names>
</name>
<name>
<surname>Jo</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Eom</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Mok</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K.U.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>H.K.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Combined vitamin C, hydrocortisone, and thiamine therapy for patients with severe pneumonia who were admitted to the intensive care unit: Propensity score-based analysis of a before-after cohort study</article-title>
<source/>J. Crit. Care
          <year>2018</year>
<volume>47</volume>
<fpage>211</fpage>
<lpage>218</lpage>
<pub-id pub-id-type="doi">10.1016/j.jcrc.2018.07.004</pub-id>
<pub-id pub-id-type="pmid">30029205</pub-id>
</element-citation>
</ref>
<ref id="B132-nutrients-12-01718">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okamoto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Makino</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Makino</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Restoration of the glucocorticoid receptor function by the phosphodiester compound of vitamins C and E, EPC-K1 L-ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6- yl hydrogen phosphate] potassium salt), via a redox-dependent mechanism</article-title>
<source/>Biochem. Pharmacol.
          <year>1998</year>
<volume>56</volume>
<fpage>79</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-2952(98)00121-X</pub-id>
<pub-id pub-id-type="pmid">9698091</pub-id>
</element-citation>
</ref>
<ref id="B133-nutrients-12-01718">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fujita</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Hirano</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Itoh</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nakanishi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Dexamethasone induces sodium-dependant vitamin C transporter in a mouse osteoblastic cell line MC3T3-E1</article-title>
<source/>Br. J. Nutr.
          <year>2001</year>
<volume>86</volume>
<fpage>145</fpage>
<lpage>149</lpage>
<pub-id pub-id-type="doi">10.1079/BJN2001406</pub-id>
<pub-id pub-id-type="pmid">11502226</pub-id>
</element-citation>
</ref>
<ref id="B134-nutrients-12-01718">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barabutis</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Khangoora</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Marik</surname>
<given-names>P.E.</given-names>
</name>
<name>
<surname>Catravas</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Hydrocortisone and Ascorbic Acid Synergistically Prevent and Repair Lipopolysaccharide-Induced Pulmonary Endothelial Barrier Dysfunction</article-title>
<source/>Chest
          <year>2017</year>
<volume>152</volume>
<fpage>954</fpage>
<lpage>962</lpage>
<pub-id pub-id-type="doi">10.1016/j.chest.2017.07.014</pub-id>
<pub-id pub-id-type="pmid">28739448</pub-id>
</element-citation>
</ref>
<ref id="B135-nutrients-12-01718">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hager</surname>
<given-names>D.N.</given-names>
</name>
<name>
<surname>Hinson</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Rothman</surname>
<given-names>R.E.</given-names>
</name>
</person-group>
<article-title>Vitamin C for Sepsis and Acute Respiratory Failure</article-title>
<source/>JAMA J. Am. Med. Assoc.
          <year>2020</year>
<volume>323</volume>
<fpage>791</fpage>
<lpage>792</lpage>
<pub-id pub-id-type="doi">10.1001/jama.2019.21984</pub-id>
</element-citation>
</ref>
<ref id="B136-nutrients-12-01718">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fowler</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Truwit</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Hite</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>P.E.</given-names>
</name>
<name>
<surname>Dewilde</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Priday</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Thacker</surname>
<given-names>L.R.</given-names>
</name>
<name>
<surname>Natarajan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Brophy</surname>
<given-names>D.F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients with Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial</article-title>
<source/>JAMA
          <year>2019</year>
<volume>322</volume>
<fpage>1261</fpage>
<lpage>1270</lpage>
<pub-id pub-id-type="doi">10.1001/jama.2019.11825</pub-id>
<pub-id pub-id-type="pmid">31573637</pub-id>
</element-citation>
</ref>
<ref id="B137-nutrients-12-01718">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cho</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ahn</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yim</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cheon</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S.G.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.H.</given-names>
</name>
</person-group>
<article-title>Influence of Vitamin C and maltose on the accuracy of three models of glucose meters</article-title>
<source/>Ann. Lab. Med.
          <year>2016</year>
<volume>36</volume>
<fpage>271</fpage>
<lpage>274</lpage>
<pub-id pub-id-type="doi">10.3343/alm.2016.36.3.271</pub-id>
<pub-id pub-id-type="pmid">26915620</pub-id>
</element-citation>
</ref>
<ref id="B138-nutrients-12-01718">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carr</surname>
<given-names>A.C.</given-names>
</name>
</person-group>
<article-title>A new clinical trial to test high-dose vitamin C in patients with COVID-19</article-title>
<source/>Crit. Care
          <year>2020</year>
<volume>24</volume>
<fpage>133</fpage>
<pub-id pub-id-type="doi">10.1186/s13054-020-02851-4</pub-id>
<pub-id pub-id-type="pmid">32264963</pub-id>
</element-citation>
</ref>
<ref id="B139-nutrients-12-01718">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hemilä</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Vitamin C and SARS coronavirus</article-title>
<source/>J. Antimicrob. Chemother.
          <year>2003</year>
<volume>52</volume>
<fpage>1049</fpage>
<lpage>1050</lpage>
<pub-id pub-id-type="doi">10.1093/jac/dkh002</pub-id>
<pub-id pub-id-type="pmid">14613951</pub-id>
</element-citation>
</ref>
<ref id="B140-nutrients-12-01718">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hemilä</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Vitamin C intake and susceptibility to pneumonia</article-title>
<source/>Pediatr. Infect. Dis. J.
          <year>1997</year>
<volume>16</volume>
<fpage>836</fpage>
<lpage>837</lpage>
<pub-id pub-id-type="doi">10.1097/00006454-199709000-00003</pub-id>
<pub-id pub-id-type="pmid">9306475</pub-id>
</element-citation>
</ref>
<ref id="B141-nutrients-12-01718">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hemilä</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Douglas</surname>
<given-names>R.M.</given-names>
</name>
</person-group>
<article-title>Vitamin C and acute respiratory infections</article-title>
<source/>Int. J. Tuberc. Lung Dis.
          <year>1999</year>
<volume>3</volume>
<fpage>756</fpage>
<lpage>761</lpage>
<pub-id pub-id-type="pmid">10488881</pub-id>
</element-citation>
</ref>
<ref id="B142-nutrients-12-01718">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grant</surname>
<given-names>W.B.</given-names>
</name>
<name>
<surname>Lahore</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>McDonnell</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Baggerly</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>French</surname>
<given-names>C.B.</given-names>
</name>
<name>
<surname>Aliano</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Bhattoa</surname>
<given-names>H.P.</given-names>
</name>
</person-group>
<article-title>Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths</article-title>
<source/>Nutrients
          <year>2020</year>
<volume>12</volume>
<elocation-id>988</elocation-id>
<pub-id pub-id-type="doi">10.3390/nu12040988</pub-id>
<pub-id pub-id-type="pmid">32252338</pub-id>
</element-citation>
</ref>
<ref id="B143-nutrients-12-01718">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hansdottir</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Monick</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Hinde</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Lovan</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Look</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Hunninghake</surname>
<given-names>G.W.</given-names>
</name>
</person-group>
<article-title>Respiratory epithelial cells convert inactive vitamin D to its active form: Potential effects on host defense</article-title>
<source/>J. Immunol.
          <year>2008</year>
<volume>181</volume>
<fpage>7090</fpage>
<lpage>7099</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.181.10.7090</pub-id>
<pub-id pub-id-type="pmid">18981129</pub-id>
</element-citation>
</ref>
<ref id="B144-nutrients-12-01718">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tripathi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tecle</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Verma</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Crouch</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hartshorn</surname>
<given-names>K.L.</given-names>
</name>
</person-group>
<article-title>The human cathelicidin LL-37 inhibits influenza a viruses through a mechanism distinct from that of surfactant protein d or defensins</article-title>
<source/>J. Gen. Virol.
          <year>2013</year>
<volume>94</volume>
<fpage>40</fpage>
<lpage>49</lpage>
<pub-id pub-id-type="doi">10.1099/vir.0.045013-0</pub-id>
<pub-id pub-id-type="pmid">23052388</pub-id>
</element-citation>
</ref>
<ref id="B145-nutrients-12-01718">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Deb</surname>
<given-names>D.K.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.C.</given-names>
</name>
</person-group>
<article-title>Vitamin D receptor inhibits nuclear factor κb activation by interacting with IκB kinase β protein</article-title>
<source/>J. Biol. Chem.
          <year>2013</year>
<volume>288</volume>
<fpage>19450</fpage>
<lpage>19458</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M113.467670</pub-id>
<pub-id pub-id-type="pmid">23671281</pub-id>
</element-citation>
</ref>
<ref id="B146-nutrients-12-01718">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonizzi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Karin</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>The two NF-κB activation pathways and their role in innate and adaptive immunity</article-title>
<source/>Trends Immunol.
          <year>2004</year>
<volume>25</volume>
<fpage>280</fpage>
<lpage>288</lpage>
<pub-id pub-id-type="doi">10.1016/j.it.2004.03.008</pub-id>
<pub-id pub-id-type="pmid">15145317</pub-id>
</element-citation>
</ref>
<ref id="B147-nutrients-12-01718">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monlezun</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Bittner</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Christopher</surname>
<given-names>K.B.</given-names>
</name>
<name>
<surname>Camargo</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Quraishi</surname>
<given-names>S.A.</given-names>
</name>
</person-group>
<article-title>Vitamin D status and acute respiratory infection: Cross sectional results from the United States national health and nutrition examination survey, 2001–2006</article-title>
<source/>Nutrients
          <year>2015</year>
<volume>7</volume>
<fpage>1933</fpage>
<lpage>1944</lpage>
<pub-id pub-id-type="doi">10.3390/nu7031933</pub-id>
<pub-id pub-id-type="pmid">25781219</pub-id>
</element-citation>
</ref>
<ref id="B148-nutrients-12-01718">
<label>148.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martineau</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Jolliffe</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Hooper</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Aloia</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Bergman</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Dubnov-Raz</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Esposito</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ganmaa</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ginde</surname>
<given-names>A.A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data</article-title>
<source/>BMJ
          <year>2017</year>
<volume>356</volume>
<pub-id pub-id-type="doi">10.1136/bmj.i6583</pub-id>
</element-citation>
</ref>
<ref id="B149-nutrients-12-01718">
<label>149.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caccialanza</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Laviano</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lobascio</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Montagna</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bruno</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ludovisi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Corsico</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Di Sabatino</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Belliato</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Calvi</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol</article-title>
<source/>Nutrition
          <year>2020</year>
<elocation-id>110835</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.nut.2020.110835</pub-id>
<pub-id pub-id-type="pmid">32280058</pub-id>
</element-citation>
</ref>
<ref id="B150-nutrients-12-01718">
<label>150.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Remuzzi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Schieppati</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Lessons from the Di Bella affair</article-title>
<source/>Lancet
          <year>1999</year>
<volume>353</volume>
<fpage>1289</fpage>
<lpage>1290</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(99)90044-2</pub-id>
<pub-id pub-id-type="pmid">10218523</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="nutrients-12-01718-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Hypothesis on the mechanism of intestinal involvement in coronavirus disease 2019 (COVID-19).</p>
</caption>
<graphic xlink:href="nutrients-12-01718-g001"></graphic>
</fig>
<fig id="nutrients-12-01718-f002" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<p>Hypothesis on the mechanisms of endothelial involvement in COVID-19.</p>
</caption>
<graphic xlink:href="nutrients-12-01718-g002"></graphic>
</fig>
<table-wrap id="nutrients-12-01718-t001" orientation="portrait" position="float">
<object-id pub-id-type="pii">nutrients-12-01718-t001_Table 1</object-id>
<label>Table 1</label>
<caption>
<p>Registered trials evaluating the possible benefits of probiotics administration in COVID-19 patients.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Study Title</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Study Type and Design</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Study Design</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Outcomes</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Evaluation of the Probiotic <italic>Lactobacillus coryniformis</italic> K8 on COVID-19 Prevention in Healthcare Workers NCT04366180</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Interventional, Randomized Active, recruiting</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">“To evaluate the effects of <italic>Lactobacillus coryniformis</italic> K8 consumption on the incidence and severity of Covid-19 in health workers exposed to the virus. This is a preventive study. Estimated enrolment: 314 participants”</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<list list-type="bullet"><list-item><p>Incidence of SARS CoV-2 infection in healthcare workers</p></list-item><list-item><p>Incidence of hospital admissions caused by SARS-CoV-2 infection</p></list-item><list-item><p>Incidence of intensive care unit (ICU) admissions caused by SARS-CoV-2 infection</p></list-item><list-item><p>Incidence of oxygen support requirement caused by SARS-CoV-2 infection</p></list-item><list-item><p>Incidence of gastrointestinal symptoms caused by SARS-CoV-2 infection</p></list-item><list-item><p>Days with body temperature &gt;37.5 °C</p></list-item><list-item><p>Days with cough</p></list-item><list-item><p>Days with fatigue</p></list-item><list-item><p>Medical treatment</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B91-nutrients-12-01718">91</xref>] </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Bacteriotherapy in the Treatment of COVID-19 (BACT-ovid) NCT04368351</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Observational, Retrospective Active, not recruiting</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">“Observational, retrospective, non-profit study on the adjuvant use of bacteriotherapy in the early control of disease progression in patients affected by COVID-19 and treated with the current standard of care on the basis of the ad interim Italian guidelines. Estimated enrolment: 70 participants”</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<list list-type="bullet"><list-item><p>Delta of time of disappearance of acute diarrhea</p></list-item><list-item><p>Delta in the number of patients requiring orotracheal intubation despite treatment</p></list-item><list-item><p>Delta of crude mortality</p></list-item><list-item><p>Delta of length of stay for patients in hospital</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B92-nutrients-12-01718">92</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Oxygen–Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora (PROBIOZOVID) NCT04366089</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Interventional, Randomized Active, recruiting</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">“Interventional, non-pharmacological, open, randomized, prospective, non-profit study on the adjuvant use of oxygen–ozone therapy plus probiotic supplementation in the early control of disease progression in patients with COVID-19. Contextually, all patients are treated with the current standard of care on the basis of the interim Italian guidelines. The main purpose of the study is to evaluate the effectiveness of an ozone therapy-based intervention (accompanied by supplementation with probiotics) in containing the progression of COVID-19 and in preventing the need for hospitalization in intensive care units.”</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<list list-type="bullet"><list-item><p>Delta in the number of patients requiring orotracheal intubation despite treatment</p></list-item><list-item><p>Delta of crude mortality</p></list-item><list-item><p>Delta of length of stay for patients in hospital</p></list-item><list-item><p>Delta in the value of interleukin (IL)-1</p></list-item><list-item><p>Delta in the value of IL-6</p></list-item><list-item><p>Delta in the value of IL-10</p></list-item><list-item><p>Delta in the value of tumor necrosis factor (TNF)-alpha</p></list-item><list-item><p>Delta in the value of cluster of differentiation</p></list-item><list-item><p>(CD)4+ CD38/human leukocyte antigen-DR isotype (HLA-DR)</p></list-item><list-item><p>Delta in the value of CD8+ CD38/HLA-DR</p></list-item><list-item><p>Delta in the value of faecal calprotectin</p></list-item><list-item><p>Delta in the value of lipopolysaccharide (LPS)</p></list-item><list-item><p>Delta in the value of zonulin</p></list-item><list-item><p>Delta in the value of alpha1-antitrypsin</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B93-nutrients-12-01718">93</xref>]</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="nutrients-12-01718-t002" orientation="portrait" position="float">
<object-id pub-id-type="pii">nutrients-12-01718-t002_Table 2</object-id>
<label>Table 2</label>
<caption>
<p>Main nutraceuticals and supplements with potential role in countering COVID-19 pathways.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Main Nutraceuticals and Supplements</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Pathway Hypothesized Against COVID-19</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Supporting Literature</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Vitamin E, Vitamin C, Carotenoids, Minerals (Zn, Mn, Cu, Se) Polyphenols</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Inflammatory cascade and hypercoagulation by anti-inflammatory and antioxidant activities (in COVID-19 pathways, the endothelium target could be relevant)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B85-nutrients-12-01718">85</xref>,<xref ref-type="bibr" rid="B86-nutrients-12-01718">86</xref>,<xref ref-type="bibr" rid="B98-nutrients-12-01718">98</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Polyphenols (flavonoids, phenolic acids, stilbenes, lignans)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Platelet aggregation and pro-thrombotic activity by suppression of thrombin and factor Xa; endogenous platelet-derived NO and superoxide production; endothelial synthesis of NO, NO signaling pathways in endothelial cells improving endothelial function and NO-dependent relaxation; modulates production of cytokines and expression of pro-inflammatory genes Antiviral effect for several viruses (not proved for SARS-CoV-2).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B95-nutrients-12-01718">95</xref>,<xref ref-type="bibr" rid="B96-nutrients-12-01718">96</xref>,<xref ref-type="bibr" rid="B97-nutrients-12-01718">97</xref>,<xref ref-type="bibr" rid="B99-nutrients-12-01718">99</xref>,<xref ref-type="bibr" rid="B100-nutrients-12-01718">100</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Curcumin</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Binds to the target receptors of SARS-CoV-2</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B106-nutrients-12-01718">106</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Combination of vitamin C, curcumin, and glycyrrhizic acid </td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Interferons production with effects on inflammatory response.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B107-nutrients-12-01718">107</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Lianhuaqingwen (Chinese patent medicine composed of 13 herbs)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">SARS-CoV-2 replication; pro-inflammatory cytokines (TNF-α, IL-6, CCL-2/MCP-1, and CXCL-10/IP-10).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B108-nutrients-12-01718">108</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Vitamin C</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Fundamental for the structural organization of the epithelial and endothelial barriers; fundamental for phagocytosis and chemotaxis; protection from ROS injury; intravenous administration against inflammation and vascular injury in sepsis and ARDS; susceptibility and outcome of low respiratory tract infections.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B98-nutrients-12-01718">98</xref>,<xref ref-type="bibr" rid="B99-nutrients-12-01718">99</xref>,<xref ref-type="bibr" rid="B105-nutrients-12-01718">105</xref>,<xref ref-type="bibr" rid="B106-nutrients-12-01718">106</xref>,<xref ref-type="bibr" rid="B107-nutrients-12-01718">107</xref>,<xref ref-type="bibr" rid="B108-nutrients-12-01718">108</xref>,<xref ref-type="bibr" rid="B109-nutrients-12-01718">109</xref>,<xref ref-type="bibr" rid="B110-nutrients-12-01718">110</xref>,<xref ref-type="bibr" rid="B122-nutrients-12-01718">122</xref>,<xref ref-type="bibr" rid="B124-nutrients-12-01718">124</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Vitamin D</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Macrophagic production of catelicidine; regulation of NF-kB activity levels of IL-6, IL1-β, TNF-α and production of GM-CSF, IL-4, IL-5, VCAM-1, ICAM-1, E-selectin; daily or weekly dose showed protective effects against acute respiratory infections.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B127-nutrients-12-01718">127</xref>,<xref ref-type="bibr" rid="B128-nutrients-12-01718">128</xref>,<xref ref-type="bibr" rid="B129-nutrients-12-01718">129</xref>,<xref ref-type="bibr" rid="B130-nutrients-12-01718">130</xref>,<xref ref-type="bibr" rid="B131-nutrients-12-01718">131</xref>]</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>